CN106906187A - A kind of bi-functional bacteriophage and purposes - Google Patents
A kind of bi-functional bacteriophage and purposes Download PDFInfo
- Publication number
- CN106906187A CN106906187A CN201710161741.1A CN201710161741A CN106906187A CN 106906187 A CN106906187 A CN 106906187A CN 201710161741 A CN201710161741 A CN 201710161741A CN 106906187 A CN106906187 A CN 106906187A
- Authority
- CN
- China
- Prior art keywords
- phage
- polypeptide
- seq
- bifunctional
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001515965 unidentified phage Species 0.000 title description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 37
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 33
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 31
- 229920001184 polypeptide Polymers 0.000 claims abstract description 30
- 230000001588 bifunctional effect Effects 0.000 claims abstract description 26
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract description 14
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract description 14
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 6
- 241000724791 Filamentous phage Species 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 20
- 239000012634 fragment Substances 0.000 claims description 16
- 238000012216 screening Methods 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 206010006187 Breast cancer Diseases 0.000 claims description 7
- 208000026310 Breast neoplasm Diseases 0.000 claims description 7
- 108020004635 Complementary DNA Proteins 0.000 claims description 6
- 238000010804 cDNA synthesis Methods 0.000 claims description 6
- 239000002299 complementary DNA Substances 0.000 claims description 6
- 238000002823 phage display Methods 0.000 claims description 6
- 239000012460 protein solution Substances 0.000 claims description 6
- 230000004614 tumor growth Effects 0.000 claims description 6
- 238000001976 enzyme digestion Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 238000001712 DNA sequencing Methods 0.000 claims description 4
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 4
- 238000002474 experimental method Methods 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 102000012410 DNA Ligases Human genes 0.000 claims description 2
- 108010061982 DNA Ligases Proteins 0.000 claims description 2
- 238000002965 ELISA Methods 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 2
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 239000004098 Tetracycline Substances 0.000 claims description 2
- 230000027455 binding Effects 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- 230000009977 dual effect Effects 0.000 claims description 2
- 102000058223 human VEGFA Human genes 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 230000009870 specific binding Effects 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 150000003522 tetracyclines Chemical class 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 230000029087 digestion Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000013519 translation Methods 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 abstract description 7
- 210000004881 tumor cell Anatomy 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000008685 targeting Effects 0.000 abstract description 5
- 206010027476 Metastases Diseases 0.000 abstract description 3
- 230000009401 metastasis Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 210000003556 vascular endothelial cell Anatomy 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 abstract 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 13
- 238000013461 design Methods 0.000 description 12
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 4
- 108010057821 leucylproline Proteins 0.000 description 4
- 101100165993 Escherichia phage N15 gene 8 gene Proteins 0.000 description 3
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 239000002870 angiogenesis inducing agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- CXQODNIBUNQWAS-CIUDSAMLSA-N Ala-Gln-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CXQODNIBUNQWAS-CIUDSAMLSA-N 0.000 description 2
- OAGVHWYIBZMWLA-YFKPBYRVSA-N Glu-Gly-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)NCC(O)=O OAGVHWYIBZMWLA-YFKPBYRVSA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- KJJROSNFBRWPHS-JYJNAYRXSA-N Phe-Glu-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KJJROSNFBRWPHS-JYJNAYRXSA-N 0.000 description 2
- QHSSUIHLAIWXEE-IHRRRGAJSA-N Pro-Tyr-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O QHSSUIHLAIWXEE-IHRRRGAJSA-N 0.000 description 2
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- RXEQOXHCHQJMSO-IHPCNDPISA-N Trp-His-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O RXEQOXHCHQJMSO-IHPCNDPISA-N 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 108010018625 phenylalanylarginine Proteins 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- VOUUHEHYSHWUHG-UWVGGRQHSA-N (2s)-2-[[2-[[2-[[2-[[(2s)-2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O VOUUHEHYSHWUHG-UWVGGRQHSA-N 0.000 description 1
- STACJSVFHSEZJV-GHCJXIJMSA-N Ala-Asn-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STACJSVFHSEZJV-GHCJXIJMSA-N 0.000 description 1
- XQGIRPGAVLFKBJ-CIUDSAMLSA-N Ala-Asn-Lys Chemical compound N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O XQGIRPGAVLFKBJ-CIUDSAMLSA-N 0.000 description 1
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- HQJKCXHQNUCKMY-GHCJXIJMSA-N Ala-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N HQJKCXHQNUCKMY-GHCJXIJMSA-N 0.000 description 1
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 1
- JJHBEVZAZXZREW-LFSVMHDDSA-N Ala-Thr-Phe Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O JJHBEVZAZXZREW-LFSVMHDDSA-N 0.000 description 1
- DPXDVGDLWJYZBH-GUBZILKMSA-N Arg-Asn-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DPXDVGDLWJYZBH-GUBZILKMSA-N 0.000 description 1
- RCAUJZASOAFTAJ-FXQIFTODSA-N Arg-Asp-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N RCAUJZASOAFTAJ-FXQIFTODSA-N 0.000 description 1
- JAYIQMNQDMOBFY-KKUMJFAQSA-N Arg-Glu-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JAYIQMNQDMOBFY-KKUMJFAQSA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- UZSQXCMNUPKLCC-FJXKBIBVSA-N Arg-Thr-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UZSQXCMNUPKLCC-FJXKBIBVSA-N 0.000 description 1
- IARGXWMWRFOQPG-GCJQMDKQSA-N Asn-Ala-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IARGXWMWRFOQPG-GCJQMDKQSA-N 0.000 description 1
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 1
- DXVMJJNAOVECBA-WHFBIAKZSA-N Asn-Gly-Asn Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O DXVMJJNAOVECBA-WHFBIAKZSA-N 0.000 description 1
- JEEFEQCRXKPQHC-KKUMJFAQSA-N Asn-Leu-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JEEFEQCRXKPQHC-KKUMJFAQSA-N 0.000 description 1
- OROMFUQQTSWUTI-IHRRRGAJSA-N Asn-Phe-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N OROMFUQQTSWUTI-IHRRRGAJSA-N 0.000 description 1
- GMUOCGCDOYYWPD-FXQIFTODSA-N Asn-Pro-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O GMUOCGCDOYYWPD-FXQIFTODSA-N 0.000 description 1
- HPNDKUOLNRVRAY-BIIVOSGPSA-N Asn-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N)C(=O)O HPNDKUOLNRVRAY-BIIVOSGPSA-N 0.000 description 1
- PIABYSIYPGLLDQ-XVSYOHENSA-N Asn-Thr-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PIABYSIYPGLLDQ-XVSYOHENSA-N 0.000 description 1
- CELPEWWLSXMVPH-CIUDSAMLSA-N Asp-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O CELPEWWLSXMVPH-CIUDSAMLSA-N 0.000 description 1
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 1
- XDGBFDYXZCMYEX-NUMRIWBASA-N Asp-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)O XDGBFDYXZCMYEX-NUMRIWBASA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 1
- HJCGDIGVVWETRO-ZPFDUUQYSA-N Asp-Lys-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(O)=O HJCGDIGVVWETRO-ZPFDUUQYSA-N 0.000 description 1
- GYWQGGUCMDCUJE-DLOVCJGASA-N Asp-Phe-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O GYWQGGUCMDCUJE-DLOVCJGASA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- PDIYGFYAMZZFCW-JIOCBJNQSA-N Asp-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N)O PDIYGFYAMZZFCW-JIOCBJNQSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- KXUKWRVYDYIPSQ-CIUDSAMLSA-N Cys-Leu-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUKWRVYDYIPSQ-CIUDSAMLSA-N 0.000 description 1
- XXDATQFUGMAJRV-XIRDDKMYSA-N Cys-Leu-Trp Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O XXDATQFUGMAJRV-XIRDDKMYSA-N 0.000 description 1
- ALNKNYKSZPSLBD-ZDLURKLDSA-N Cys-Thr-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ALNKNYKSZPSLBD-ZDLURKLDSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- CKNUKHBRCSMKMO-XHNCKOQMSA-N Gln-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O CKNUKHBRCSMKMO-XHNCKOQMSA-N 0.000 description 1
- PZVJDMJHKUWSIV-AVGNSLFASA-N Gln-Cys-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)N)O PZVJDMJHKUWSIV-AVGNSLFASA-N 0.000 description 1
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 1
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 1
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 1
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 1
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 1
- JKDBRTNMYXYLHO-JYJNAYRXSA-N Gln-Tyr-Leu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 JKDBRTNMYXYLHO-JYJNAYRXSA-N 0.000 description 1
- UQKVUFGUSVYJMQ-IRIUXVKKSA-N Gln-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)N)N)O UQKVUFGUSVYJMQ-IRIUXVKKSA-N 0.000 description 1
- AKJRHDMTEJXTPV-ACZMJKKPSA-N Glu-Asn-Ala Chemical compound C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AKJRHDMTEJXTPV-ACZMJKKPSA-N 0.000 description 1
- YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 1
- RDDSZZJOKDVPAE-ACZMJKKPSA-N Glu-Asn-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDDSZZJOKDVPAE-ACZMJKKPSA-N 0.000 description 1
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 1
- FLQAKQOBSPFGKG-CIUDSAMLSA-N Glu-Cys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FLQAKQOBSPFGKG-CIUDSAMLSA-N 0.000 description 1
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 1
- FGSGPLRPQCZBSQ-AVGNSLFASA-N Glu-Phe-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O FGSGPLRPQCZBSQ-AVGNSLFASA-N 0.000 description 1
- QGAJQIGFFIQJJK-IHRRRGAJSA-N Glu-Tyr-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O QGAJQIGFFIQJJK-IHRRRGAJSA-N 0.000 description 1
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- MHZXESQPPXOING-KBPBESRZSA-N Gly-Lys-Phe Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MHZXESQPPXOING-KBPBESRZSA-N 0.000 description 1
- WDEHMRNSGHVNOH-VHSXEESVSA-N Gly-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)CN)C(=O)O WDEHMRNSGHVNOH-VHSXEESVSA-N 0.000 description 1
- MTBIKIMYHUWBRX-QWRGUYRKSA-N Gly-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN MTBIKIMYHUWBRX-QWRGUYRKSA-N 0.000 description 1
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- YXTFLTJYLIAZQG-FJXKBIBVSA-N Gly-Thr-Arg Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YXTFLTJYLIAZQG-FJXKBIBVSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 1
- WSWWTQYHFCBKBT-DVJZZOLTSA-N Gly-Thr-Trp Chemical compound C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O WSWWTQYHFCBKBT-DVJZZOLTSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- UKTUOMWSJPXODT-GUDRVLHUSA-N Ile-Asn-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N UKTUOMWSJPXODT-GUDRVLHUSA-N 0.000 description 1
- XLDYDEDTGMHUCZ-GHCJXIJMSA-N Ile-Asp-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N XLDYDEDTGMHUCZ-GHCJXIJMSA-N 0.000 description 1
- CDGLBYSAZFIIJO-RCOVLWMOSA-N Ile-Gly-Gly Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O CDGLBYSAZFIIJO-RCOVLWMOSA-N 0.000 description 1
- MQFGXJNSUJTXDT-QSFUFRPTSA-N Ile-Gly-Ile Chemical compound N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)O MQFGXJNSUJTXDT-QSFUFRPTSA-N 0.000 description 1
- KCTIFOCXAIUQQK-QXEWZRGKSA-N Ile-Pro-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O KCTIFOCXAIUQQK-QXEWZRGKSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- HBJZFCIVFIBNSV-DCAQKATOSA-N Leu-Arg-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O HBJZFCIVFIBNSV-DCAQKATOSA-N 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- ARRIJPQRBWRNLT-DCAQKATOSA-N Leu-Met-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ARRIJPQRBWRNLT-DCAQKATOSA-N 0.000 description 1
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 1
- VQHUBNVKFFLWRP-ULQDDVLXSA-N Leu-Tyr-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 VQHUBNVKFFLWRP-ULQDDVLXSA-N 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- WQWZXKWOEVSGQM-DCAQKATOSA-N Lys-Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN WQWZXKWOEVSGQM-DCAQKATOSA-N 0.000 description 1
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 1
- XIZQPFCRXLUNMK-BZSNNMDCSA-N Lys-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N XIZQPFCRXLUNMK-BZSNNMDCSA-N 0.000 description 1
- ATNKHRAIZCMCCN-BZSNNMDCSA-N Lys-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N ATNKHRAIZCMCCN-BZSNNMDCSA-N 0.000 description 1
- MSSABBQOBUZFKZ-IHRRRGAJSA-N Lys-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O MSSABBQOBUZFKZ-IHRRRGAJSA-N 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 1
- KBTQZYASLSUFJR-KKUMJFAQSA-N Met-Phe-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KBTQZYASLSUFJR-KKUMJFAQSA-N 0.000 description 1
- MUDYEFAKNSTFAI-JYJNAYRXSA-N Met-Tyr-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O MUDYEFAKNSTFAI-JYJNAYRXSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 1
- JJHVFCUWLSKADD-ONGXEEELSA-N Phe-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O JJHVFCUWLSKADD-ONGXEEELSA-N 0.000 description 1
- MYQCCQSMKNCNKY-KKUMJFAQSA-N Phe-His-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)O)N MYQCCQSMKNCNKY-KKUMJFAQSA-N 0.000 description 1
- MJQFZGOIVBDIMZ-WHOFXGATSA-N Phe-Ile-Gly Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O MJQFZGOIVBDIMZ-WHOFXGATSA-N 0.000 description 1
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 1
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 1
- JHSRGEODDALISP-XVSYOHENSA-N Phe-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O JHSRGEODDALISP-XVSYOHENSA-N 0.000 description 1
- DXWNFNOPBYAFRM-IHRRRGAJSA-N Phe-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N DXWNFNOPBYAFRM-IHRRRGAJSA-N 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- QGOZJLYCGRYYRW-KKUMJFAQSA-N Pro-Glu-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QGOZJLYCGRYYRW-KKUMJFAQSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- FIDNSJUXESUDOV-JYJNAYRXSA-N Pro-Tyr-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O FIDNSJUXESUDOV-JYJNAYRXSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- JPIDMRXXNMIVKY-VZFHVOOUSA-N Ser-Ala-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPIDMRXXNMIVKY-VZFHVOOUSA-N 0.000 description 1
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 1
- YMAWDPHQVABADW-CIUDSAMLSA-N Ser-Gln-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O YMAWDPHQVABADW-CIUDSAMLSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- RRRRCRYTLZVCEN-HJGDQZAQSA-N Thr-Leu-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O RRRRCRYTLZVCEN-HJGDQZAQSA-N 0.000 description 1
- WFAUDCSNCWJJAA-KXNHARMFSA-N Thr-Lys-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(O)=O WFAUDCSNCWJJAA-KXNHARMFSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 1
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 1
- HVHJYXDXRIWELT-RYUDHWBXSA-N Tyr-Glu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O HVHJYXDXRIWELT-RYUDHWBXSA-N 0.000 description 1
- SLCSPPCQWUHPPO-JYJNAYRXSA-N Tyr-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SLCSPPCQWUHPPO-JYJNAYRXSA-N 0.000 description 1
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 1
- VXFXIBCCVLJCJT-JYJNAYRXSA-N Tyr-Pro-Pro Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O VXFXIBCCVLJCJT-JYJNAYRXSA-N 0.000 description 1
- ZZDYJFVIKVSUFA-WLTAIBSBSA-N Tyr-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ZZDYJFVIKVSUFA-WLTAIBSBSA-N 0.000 description 1
- GAKBTSMAPGLQFA-JNPHEJMOSA-N Tyr-Thr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 GAKBTSMAPGLQFA-JNPHEJMOSA-N 0.000 description 1
- YMZYSCDRTXEOKD-IHPCNDPISA-N Tyr-Trp-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N YMZYSCDRTXEOKD-IHPCNDPISA-N 0.000 description 1
- QPZMOUMNTGTEFR-ZKWXMUAHSA-N Val-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N QPZMOUMNTGTEFR-ZKWXMUAHSA-N 0.000 description 1
- OQWNEUXPKHIEJO-NRPADANISA-N Val-Glu-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N OQWNEUXPKHIEJO-NRPADANISA-N 0.000 description 1
- USLVEJAHTBLSIL-CYDGBPFRSA-N Val-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C USLVEJAHTBLSIL-CYDGBPFRSA-N 0.000 description 1
- QTXGUIMEHKCPBH-FHWLQOOXSA-N Val-Trp-Lys Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 QTXGUIMEHKCPBH-FHWLQOOXSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 230000005747 tumor angiogenesis Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14111—Inoviridae
- C12N2795/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14111—Inoviridae
- C12N2795/14141—Use of virus, viral particle or viral elements as a vector
- C12N2795/14142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14111—Inoviridae
- C12N2795/14141—Use of virus, viral particle or viral elements as a vector
- C12N2795/14145—Special targeting system for viral vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种双功能性噬菌体及用途,本发明通过噬菌体生物淘选成功获得了能和血管内皮生长因子VEGF特异识别的WR多肽。然后将该WR多肽和肿瘤的靶向识别肽同时展示在丝状噬菌体上形成双功能性噬菌体。这种噬菌体既能特异地识别肿瘤还能阻断肿瘤细胞分泌的VEGF进入肿瘤周围的血管内皮细胞,从而抑制肿瘤周围的新血管的形成。通过该技术使肿瘤细胞得不到足够的营养物质而不能增殖,不能顺利通过毛细血管实现肿瘤转移。该发明克服了传统药物靶向性缺乏,成本高,制备复杂等缺点。
The invention discloses a bifunctional phage and its use. The invention successfully obtains a WR polypeptide capable of specifically recognizing vascular endothelial growth factor VEGF through phage biopanning. Then, the WR polypeptide and the tumor targeting recognition peptide are simultaneously displayed on the filamentous phage to form a bifunctional phage. This phage can not only specifically recognize the tumor but also block the VEGF secreted by the tumor cell from entering the vascular endothelial cells around the tumor, thereby inhibiting the formation of new blood vessels around the tumor. Through this technology, tumor cells cannot proliferate due to lack of sufficient nutrients, and tumor metastasis cannot be successfully achieved through capillaries. The invention overcomes the shortcomings of traditional drugs such as lack of targeting, high cost and complicated preparation.
Description
技术领域technical field
本发明属于纳米医学领域,涉及一种双功能性噬菌体及其在抑制肿瘤生长方面的用途。The invention belongs to the field of nanomedicine and relates to a bifunctional phage and its application in inhibiting tumor growth.
背景技术Background technique
1979年哈佛大学Folkman博士提出了著名的肿瘤血管生成假说,经过近三十年的研究被接受。该假说认为肿瘤在缺氧等的情况下会高表达一系列内源性血管生成因子,而静止的内皮细胞被这些细胞因子激活以后经过细胞增殖、迁徙并排列成管腔结构。肿瘤体积增长和转移需要依靠这些新生的血管来提供营养,排除代谢物和提供路径。这个假设被很多实验证明:鸡胚胎绒毛膜(CAM)上的肿瘤在无血管期生长受限,但在血管形成以后迅速生长;小鼠皮下移植肿瘤体积在血管形成前呈线性增加,在血管形成后呈指数增加;小鼠的皮下肿瘤生长过程血管占肿瘤体积增加,最后达到1.5%;体外球状肿瘤在无血管的情况下只能达到2mm3,在体内直径也只能达到0.4mm;乳腺癌中血管血管内皮细胞增殖比癌旁间质内皮细胞快45倍;在血管形成前血液中的循环肿瘤细胞极少,仅在血管化后才大量出现;肿瘤的新生血管基底膜不连续呈碎片状,易于“渗漏”肿瘤细胞;新生血管分泌的胶原酶和血浆纤溶酶原激活物还协助肿瘤细胞侵袭周围结蹄组织和淋巴管。故血管生成因子是肿瘤治疗的一个很重要的靶点:通过中和、抑制重要的血管生成因子(如:VEGF)来抑制肿瘤新血管形成,从而达到“饥饿”肿瘤的目的。In 1979, Dr. Folkman of Harvard University proposed the famous tumor angiogenesis hypothesis, which was accepted after nearly 30 years of research. The hypothesis holds that tumors highly express a series of endogenous angiogenic factors under conditions such as hypoxia, and quiescent endothelial cells are activated by these cytokines and undergo cell proliferation, migration and arrangement into a luminal structure. Tumor volume growth and metastasis need to rely on these new blood vessels to provide nutrients, remove metabolites and provide pathways. This hypothesis has been proved by many experiments: the growth of tumors on chick embryonic chorion (CAM) is limited in the avascular stage, but grows rapidly after vascularization; the volume of subcutaneously transplanted tumors in mice increases linearly before vascularization, and grows rapidly after vascularization. Afterwards, it increases exponentially; during the growth process of subcutaneous tumors in mice, blood vessels accounted for an increase in tumor volume, and finally reached 1.5%; in vitro spherical tumors can only reach 2mm 3 in the absence of blood vessels, and the diameter in vivo can only reach 0.4mm; breast cancer Endothelial cells proliferate 45 times faster than endothelial cells in adjacent mesenchymal vessels; there are very few circulating tumor cells in the blood before angiogenesis, and only appear in large numbers after vascularization; the neovascular basement membrane of the tumor is discontinuous and fragmented , easy to "leak" tumor cells; collagenase and plasma plasminogen activator secreted by new blood vessels also assist tumor cells to invade the surrounding knot tissue and lymphatic vessels. Therefore, angiogenesis factors are a very important target for tumor therapy: by neutralizing and inhibiting important angiogenesis factors (such as: VEGF) to inhibit tumor neovascularization, so as to achieve the purpose of "starving" tumors.
丝状噬菌体是一种由外壳蛋白围绕基因组形成的900nm、直径为6.5nm的生物纳米纤维。它像其他纳米颗粒一样具有较大的比表面积,所以能携带大量的分子药物;同时,它分子量较大具有很强的免疫原性,比较容易机体产生免疫反应,很容易被机体清除。因为噬菌体是特异性针对细菌的病毒颗粒,所以对人体而言是一种安全的纳米材料。并且噬菌体还可以通过噬菌体展示技术和生物淘选获得与目标靶向物(如:纳米颗粒、蛋白质、细胞和器官)特异性识别的结合肽。故丝状噬菌体是一种具有巨大潜能的靶向阻断药物载体。但目前很多研究只利用了它的靶向性,而未尝试在一个噬菌体上同时展示靶向性功能肽和治疗性功能肽。Filamentous phages are biological nanofibers of 900 nm and 6.5 nm in diameter formed by coat proteins surrounding the genome. Like other nanoparticles, it has a large specific surface area, so it can carry a large amount of molecular drugs; at the same time, its large molecular weight has strong immunogenicity, and it is easier for the body to produce an immune response and is easily eliminated by the body. Because phages are virus particles that specifically target bacteria, they are safe nanomaterials for humans. And phage can also obtain binding peptides specifically recognized by target targets (such as nanoparticles, proteins, cells and organs) through phage display technology and biopanning. Therefore, filamentous phage is a target-blocking drug carrier with great potential. However, many current studies have only used its targeting, but have not attempted to simultaneously display targeting functional peptides and therapeutic functional peptides on a phage.
发明内容Contents of the invention
本发明的目的在于针对现有技术的不足,提供一种双功能性噬菌体及用途。The object of the present invention is to provide a bifunctional phage and its use in view of the deficiencies of the prior art.
本发明的目的是通过以下技术方案实现的:一种双功能性噬菌体,它通过以下方法制备得到:The object of the present invention is achieved by the following technical solutions: a bifunctional phage prepared by the following method:
(1)利用噬菌体多肽文库,通过生物淘选筛选出针对人血管内皮生长因子的特异性结合肽WR;(1) Using a phage polypeptide library, screening out the specific binding peptide WR for human vascular endothelial growth factor through biopanning;
(2)将步骤(1)中的WR多肽和能特异性识别原位乳腺癌肿瘤的AR多肽分别展示在双展示噬菌体fd388的p3和p8蛋白上,形成双功能性噬菌体fd388-AR-WR。(2) The WR polypeptide in step (1) and the AR polypeptide capable of specifically recognizing orthotopic breast cancer tumors are respectively displayed on the p3 and p8 proteins of the double display phage fd388 to form a bifunctional phage fd388-AR-WR.
一种上述双功能性噬菌体在制备抑制肿瘤生长药物方面的用途。A use of the above-mentioned bifunctional phage in preparing drugs for inhibiting tumor growth.
本发明的有益效果是,本发明利用生物淘选技术筛选获得了能与VEGF蛋白特异结合的多肽(WR),并将该多肽和一个人乳腺癌特异识别肽通过噬菌体展示技术分别展示在噬菌体的p8和p3位置并制备出了能同时结合肿瘤和VEGF的双功能性噬菌体;该噬菌体既能特异地识别肿瘤还能阻断肿瘤细胞分泌的VEGF进入肿瘤周围的血管内皮细胞,从而抑制肿瘤周围的新血管的形成。通过该技术使肿瘤细胞得不到足够的营养物质而不能增殖,不能顺利通过毛细血管实现肿瘤转移。本发明克服了传统药物靶向性缺乏,成本高,制备复杂等缺点。The beneficial effect of the present invention is that the present invention uses bio-panning technology to screen and obtain a polypeptide (WR) that can specifically bind to VEGF protein, and the polypeptide and a human breast cancer-specific recognition peptide are displayed on the phage respectively by phage display technology. p8 and p3 positions and prepared a bifunctional phage that can bind tumors and VEGF at the same time; the phage can not only specifically recognize tumors but also block VEGF secreted by tumor cells from entering the vascular endothelial cells around the tumor, thereby inhibiting the vascular endothelial cells around the tumor. The formation of new blood vessels. Through this technology, tumor cells cannot proliferate due to lack of sufficient nutrients, and tumor metastasis cannot be successfully achieved through capillaries. The invention overcomes the shortcomings of traditional medicines such as lack of targeting, high cost, complicated preparation and the like.
附图说明Description of drawings
图1为fd388-AR-WR双功能性噬菌体的TEM图;Figure 1 is a TEM image of fd388-AR-WR bifunctional phage;
图2为肿瘤经过fd388-AR-WR双功能性噬菌体治疗后重量统计图;Figure 2 is a statistical diagram of tumor weight after treatment with fd388-AR-WR bifunctional phage;
图3为肿瘤经过fd388-AR-WR双功能性噬菌体治疗后的直观图。Figure 3 is a visualization of tumors treated with fd388-AR-WR bifunctional phage.
具体实施方式detailed description
下面通过实施例对本发明作进一步的详细说明,以下实施例是对本发明的解释而本发明并不局限于以下实施例。The present invention will be described in further detail below through examples, and the following examples are explanations of the present invention and the present invention is not limited to the following examples.
实施例1:Example 1:
1、生物淘选:1. Biological panning:
1.1、使用0.1M NaHCO3包被液将VEGF蛋白稀释成四个梯度浓度20g/mL、4g/mL、0.8g/mL、0.16g/mL。1.1. Use 0.1M NaHCO3 coating solution to dilute VEGF protein into four gradient concentrations of 20g/mL, 4g/mL, 0.8g/mL, and 0.16g/mL.
1.2、将400μL的浓度为20g/mL的蛋白溶液孵育在24孔细胞培养板中4℃过夜。1.2. Incubate 400 μL of protein solution with a concentration of 20 g/mL in a 24-well cell culture plate overnight at 4°C.
1.3、弃掉蛋白溶液,加入500μL的5mg/mL BSA溶液,37℃封闭2小时;弃掉封闭液。1.3. Discard the protein solution, add 500 μL of 5 mg/mL BSA solution, block at 37°C for 2 hours; discard the blocking solution.
1.4、加入500μL的吐温-20的体积百分比为5%的PBST溶液孵育6分钟,弃掉,重复6次。1.4. Add 500 μL of 5% Tween-20 in PBST solution and incubate for 6 minutes, discard and repeat 6 times.
1.5、将含有1010pfu噬菌体库的400μL PBS作为输入加入,37℃封闭1小时,弃掉上清液。1.5. Add 400 μL PBS containing 10 10 pfu phage library as input, block at 37°C for 1 hour, and discard the supernatant.
1.6、加入500μL的吐温-20的体积百分比为5%的PBST溶液孵育6分钟,弃掉,重复6次,洗掉未结合的和非特异性结合的噬菌体。1.6. Add 500 μL of 5% Tween-20 in PBST solution and incubate for 6 minutes, discard and repeat 6 times to wash away unbound and non-specifically bound phages.
1.7、加入400μL的pH=2.2的0.1M HCl孵育5-10分钟,将特异结合的噬菌体洗脱下来;然后立即加入60μL的pH=9.1的1M Tris-HCl溶液中和,将得到的噬菌体通过侵染细菌进行扩增,得到扩增后的噬菌体,完成第一轮筛选。1.7. Add 400 μL of 0.1M HCl with pH=2.2 and incubate for 5-10 minutes to elute the specifically bound phages; then immediately add 60 μL of 1M Tris-HCl solution with pH=9.1 for neutralization, and pass the obtained phages Infected bacteria were amplified to obtain amplified phages, and the first round of screening was completed.
1.8、依次用浓度为4g/mL、0.8g/mL、0.16g/mL的蛋白溶液按步骤1.2-1.7完成第2-4轮的筛选,每次筛选的输入为上一轮得到的扩增后的噬菌体。1.8. Use protein solutions with concentrations of 4g/mL, 0.8g/mL, and 0.16g/mL in turn to complete the 2nd-4th round of screening according to steps 1.2-1.7, and the input for each screening is the amplification obtained in the previous round. of bacteriophages.
1.9、经过四轮筛选获得一些与VEGF特意结合的噬菌体,然后将这些噬菌体的基因组进行DNA测序。1.9. After four rounds of screening, some phages specifically combined with VEGF were obtained, and then the genomes of these phages were subjected to DNA sequencing.
2、验证亲和力:将步骤1中DNA测序出现频率出现高的噬菌体和VEGF蛋白进行噬菌体ELISA实验和斑点杂交实验。实验结果显示携带有WR多肽的噬菌体和VEGF具有最高的亲和力。所述携带有WR多肽的氨基酸序列如SEQ ID NO.1所示。2. Verify affinity: perform phage ELISA and dot hybridization experiments on the phages and VEGF proteins that appear frequently in DNA sequencing in step 1. The experimental results showed that the phage carrying the WR polypeptide had the highest affinity to VEGF. The amino acid sequence of the WR-carrying polypeptide is shown in SEQ ID NO.1.
3、噬菌体展示:将编码WR多肽的双链互补DNA序列两端添加PstI/HindIII酶切位点,编码乳腺癌肿瘤特异识别多肽(AR,其氨基酸序列如SEQ ID NO.9所示)的DNA序列两端添加SfiI酶切位点。WR多肽对应的双链互补DNA序列如SEQ ID NO.2和SEQ ID NO.11所示,AR多肽对应的双链互补DNA序列如SEQ ID NO.3和SEQ ID NO.12所示;将fd388噬菌体展示载体利用PstI和HindIII酶切,并与设计好的带有PstI/HindIII酶切位点的编码WR多肽的DNA片段通过T4连接酶进行连接;成功插入WR多肽对应DNA的fd388-WR,再使用SfiI进行酶切,并与设计好的带有SfiI酶切位点的编码AR多肽的DNA片段连接形成fd388-AR-WR双功能性噬菌体的基因组;然后将该基因组转化入大肠杆菌中转录、翻译、组装成双功能性噬菌体,所述fd388-AR-WR双展示噬菌体的重组p3蛋白和重组p8蛋白的氨基酸序列如SEQ IDNO.4和SEQ ID NO.5所示;最后将构建好的噬菌体加入含有PEG8000和NaCl的溶液中进行纯化,噬菌体与溶液的体积比为6:1,溶液中,PEG8000的质量浓度为16.7%,NaCl的摩尔浓度为3.3M。3. Phage display: Add PstI/HindIII restriction sites to both ends of the double-stranded complementary DNA sequence encoding the WR polypeptide, and encode the DNA of breast cancer tumor-specific recognition polypeptide (AR, whose amino acid sequence is shown in SEQ ID NO.9) Add SfiI restriction sites at both ends of the sequence. The double-stranded complementary DNA sequence corresponding to the WR polypeptide is shown in SEQ ID NO.2 and SEQ ID NO.11, and the double-stranded complementary DNA sequence corresponding to the AR polypeptide is shown in SEQ ID NO.3 and SEQ ID NO.12; the fd388 The phage display vector was digested with PstI and HindIII, and ligated with the designed DNA fragment encoding the WR polypeptide with PstI/HindIII restriction sites through T4 ligase; the fd388-WR corresponding to the DNA of the WR polypeptide was successfully inserted, and then Use SfiI to digest, and connect with the designed DNA fragment encoding AR polypeptide with SfiI restriction site to form the genome of fd388-AR-WR bifunctional phage; then transform the genome into Escherichia coli for transcription, Translated and assembled into a bifunctional phage, the fd388-AR-WR dual display phage recombinant p3 protein and recombinant p8 protein amino acid sequences are shown in SEQ ID NO.4 and SEQ ID NO.5; finally the constructed phage Purify by adding into a solution containing PEG8000 and NaCl, the volume ratio of the phage to the solution is 6:1, the mass concentration of PEG8000 in the solution is 16.7%, and the molar concentration of NaCl is 3.3M.
所述fd388噬菌体展示载体通过以下步骤制备得到:The fd388 phage display vector is prepared by the following steps:
(a)获得重组gene3:按照New England Biolab公司的BsrGI/BamHI双酶切体系加入fUSE55载体(序列如SEQ ID NO.6所示)37℃双酶切3h;利用Qiagen公司的质粒回收试剂盒回收小片段以获得包含有重组gene3的长为1222bp的DNA片段1。其中,所述fUSE55是通过overlap PCR实验将含有2个SfiI酶切位点(SEQ ID NO.8:GCCGACGTGGCCCGGCCTCTGGGGCC)的DNA片段插入野生fd噬菌体的gene3的5’端获得。(a) Obtain recombinant gene3: Add fUSE55 vector (sequence shown in SEQ ID NO.6) according to New England Biolab's BsrGI/BamHI double enzyme digestion system for 3 hours at 37°C; use Qiagen's plasmid recovery kit to recover A small fragment was obtained to obtain a 1222bp DNA fragment 1 containing the recombinant gene3. Wherein, the fUSE55 is obtained by inserting a DNA fragment containing two SfiI restriction sites (SEQ ID NO.8: GCCGACGTGGCCCGGCCTCTGGGGCC) into the 5' end of gene3 of wild fd phage through an overlap PCR experiment.
(b)获得噬菌体基因组其他部分:按照New England Biolab公司的BsrGI/BamHI双酶切体系加入f88-4载体(序列如SEQ ID NO.7所示)37℃双酶切3h;利用Qiagen公司的质粒回收试剂盒回收大片段以获得包含有噬菌体基因组中除去DNA片段1剩下的长为8034bp的DNA片段2。其中f88-4载体是通过overlap PCR反应将PstI和HindIII酶切位点插入野生gene8的5’端获得工程化gene8,并将工程化的gene8插入野生的fd噬菌体获得。(b) Obtain other parts of the phage genome: add the f88-4 vector (sequence shown in SEQ ID NO.7) according to the BsrGI/BamHI double enzyme digestion system of New England Biolab Company and perform double enzyme digestion at 37°C for 3 hours; use the plasmid from Qiagen Company The recovery kit recovers large fragments to obtain DNA fragment 2 with a length of 8034bp remaining after removing DNA fragment 1 in the phage genome. The f88-4 vector is obtained by inserting the PstI and HindIII restriction sites into the 5' end of the wild gene8 by overlapping PCR reaction to obtain the engineered gene8, and inserting the engineered gene8 into the wild fd phage.
(c)构建双展示载体fd388:将DNA片段1和DNA片段2按1:3的比例,通过T4DNA连接酶16℃过夜连接。(c) Construction of double display vector fd388: DNA fragment 1 and DNA fragment 2 were ligated at a ratio of 1:3 by T4 DNA ligase overnight at 16°C.
(d)将连接产物转化进入JM109感受态细胞,并涂抹在四环素抗性平板上37℃过夜获取阳性单克隆,得到可异位展示两种多肽的噬菌体双展示载体,所述噬菌体双展示载体的序列如SEQ ID NO.10所示。(d) Transform the ligation product into JM109 competent cells, and smear it on a tetracycline-resistant plate at 37°C overnight to obtain positive single clones, and obtain a phage double display vector capable of ectopically displaying two polypeptides, and the phage double display vector The sequence is shown in SEQ ID NO.10.
4、原位异种乳腺癌小鼠模型的建立:首先在4周龄的免疫缺陷小鼠背部植入一颗0.36mg/pellet的17β雌二醇缓释片(Innovative Research of America);第二天在第二对乳腺的脂肪垫注射100μL的107MCF-7细胞。4. Establishment of an orthotopic xenogeneic breast cancer mouse model: First, a 0.36mg/pellet 17βestradiol sustained-release tablet (Innovative Research of America) was implanted on the back of a 4-week-old immunodeficient mouse; the next day Inject 100 μL of 10 7 MCF-7 cells in the fat pad of the second pair of mammary glands.
5、肿瘤生长抑制监测:从步骤4中原位肿瘤模型成功建立10天以后起,每隔1天在小鼠尾静脉注射入100μL步骤3中纯化的双功能性噬菌体,并测量肿瘤的长和宽和小鼠体重;以PBS溶液作对照;经过10次注射治疗,剥离出肿瘤并称重,做HE染色和免疫组化验证血管密度;收集小鼠血液体外检测噬菌体的溶血效应;剥离主要器官(比如肾脏、肝脏和脾脏)做HE染色和免疫组化。图2和图3是荷瘤小鼠经过fd388-AR-WR双功能性噬菌体、WT野生型噬菌体(阴性对照)和PBS(空白对照组)治疗后的肿瘤重量统计图和直观图。结果显示fd388-AR-WR双功能性噬菌体相对于WT野生型噬菌体和PBS能更加显著的抑制肿瘤的生长。5. Tumor growth inhibition monitoring: 10 days after the successful establishment of the orthotopic tumor model in step 4, inject 100 μL of the bifunctional phage purified in step 3 into the tail vein of the mouse every other day, and measure the length and width of the tumor and mouse body weight; use PBS solution as a control; after 10 times of injection treatment, the tumor was stripped out and weighed, and HE staining and immunohistochemistry were performed to verify the blood vessel density; the blood of the mice was collected to detect the hemolytic effect of phage in vitro; the main organs ( Such as kidney, liver and spleen) for HE staining and immunohistochemistry. Fig. 2 and Fig. 3 are tumor weight statistics and visual diagrams of tumor-bearing mice treated with fd388-AR-WR bifunctional phage, WT wild-type phage (negative control) and PBS (blank control group). The results showed that fd388-AR-WR bifunctional phage could inhibit tumor growth more significantly than WT wild-type phage and PBS.
SEQUENCE LISTINGSEQUENCE LISTING
<110> 浙江大学<110> Zhejiang University
<120> 一种双功能性噬菌体及用途<120> A bifunctional phage and its use
<160> 12<160> 12
<170> PatentIn version 3.3<170> PatentIn version 3.3
<210> 1<210> 1
<211> 12<211> 12
<212> PRT<212> PRT
<213> 人工设计<213> artificial design
<400> 1<400> 1
Trp His Leu Pro Tyr Asn Phe Glu Leu Ala Gln ArgTrp His Leu Pro Tyr Asn Phe Glu Leu Ala Gln Arg
1 5 101 5 10
<210> 2<210> 2
<211> 51<211> 51
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 2<400> 2
agctttgcct ggcatcttcc ttataatttt gagcttgcgc agcgtggtgc a 51agctttgcct ggcatcttcc ttataatttt gagcttgcgc agcgtggtgc a 51
<210> 3<210> 3
<211> 51<211> 51
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 3<400> 3
aagcgaggga gtatggcacc aggtttagcc tcatcggagg ctatcgcact g 51aagcgaggga gtatggcacc aggtttagcc tcatcggagg ctatcgcact g 51
<210> 4<210> 4
<211> 425<211> 425
<212> PRT<212> PRT
<213> 人工设计<213> artificial design
<400> 4<400> 4
Ala Asp Ala Arg Glu Tyr Gly Thr Arg Phe Ser Leu Ile Gly Gly TyrAla Asp Ala Arg Glu Tyr Gly Thr Arg Phe Ser Leu Ile Gly Gly Tyr
1 5 10 151 5 10 15
Arg Thr Gly Ala Glu Thr Val Glu Ser Cys Leu Ala Lys Pro His ThrArg Thr Gly Ala Glu Thr Val Glu Ser Cys Leu Ala Lys Pro His Thr
20 25 30 20 25 30
Glu Asn Ser Phe Thr Asn Val Trp Lys Asp Asp Lys Thr Leu Asp ArgGlu Asn Ser Phe Thr Asn Val Trp Lys Asp Asp Lys Thr Leu Asp Arg
35 40 45 35 40 45
Tyr Ala Asn Tyr Glu Gly Cys Leu Trp Asn Ala Thr Gly Val Val ValTyr Ala Asn Tyr Glu Gly Cys Leu Trp Asn Ala Thr Gly Val Val Val
50 55 60 50 55 60
Cys Thr Gly Asp Glu Thr Gln Cys Tyr Gly Thr Trp Val Pro Ile GlyCys Thr Gly Asp Glu Thr Gln Cys Tyr Gly Thr Trp Val Pro Ile Gly
65 70 75 8065 70 75 80
Leu Ala Ile Pro Glu Asn Glu Gly Gly Gly Ser Glu Gly Gly Gly SerLeu Ala Ile Pro Glu Asn Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser
85 90 95 85 90 95
Glu Gly Gly Gly Ser Glu Gly Gly Gly Thr Lys Pro Pro Glu Tyr GlyGlu Gly Gly Gly Ser Glu Gly Gly Gly Thr Lys Pro Pro Glu Tyr Gly
100 105 110 100 105 110
Asp Thr Pro Ile Pro Gly Tyr Thr Tyr Ile Asn Pro Leu Asp Gly ThrAsp Thr Pro Ile Pro Gly Tyr Thr Tyr Ile Asn Pro Leu Asp Gly Thr
115 120 125 115 120 125
Tyr Pro Pro Gly Thr Glu Gln Asn Pro Ala Asn Pro Asn Pro Ser LeuTyr Pro Pro Gly Thr Glu Gln Asn Pro Ala Asn Pro Asn Pro Ser Leu
130 135 140 130 135 140
Glu Glu Ser Gln Pro Leu Asn Thr Phe Met Phe Gln Asn Asn Arg PheGlu Glu Ser Gln Pro Leu Asn Thr Phe Met Phe Gln Asn Asn Arg Phe
145 150 155 160145 150 155 160
Arg Asn Arg Gln Gly Ala Leu Thr Val Tyr Thr Gly Thr Val Thr GlnArg Asn Arg Gln Gly Ala Leu Thr Val Tyr Thr Gly Thr Val Thr Gln
165 170 175 165 170 175
Gly Thr Asp Pro Val Lys Thr Tyr Tyr Gln Tyr Thr Pro Val Ser SerGly Thr Asp Pro Val Lys Thr Tyr Tyr Gln Tyr Thr Pro Val Ser Ser
180 185 190 180 185 190
Lys Ala Met Tyr Asp Ala Tyr Trp Asn Gly Lys Phe Arg Asp Cys AlaLys Ala Met Tyr Asp Ala Tyr Trp Asn Gly Lys Phe Arg Asp Cys Ala
195 200 205 195 200 205
Phe His Ser Gly Phe Asn Glu Asp Pro Phe Val Cys Glu Tyr Gln GlyPhe His Ser Gly Phe Asn Glu Asp Pro Phe Val Cys Glu Tyr Gln Gly
210 215 220 210 215 220
Gln Ser Ser Asp Leu Pro Gln Pro Pro Val Asn Ala Gly Gly Gly SerGln Ser Ser Asp Leu Pro Gln Pro Pro Val Asn Ala Gly Gly Gly Ser
225 230 235 240225 230 235 240
Gly Gly Gly Ser Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly GlyGly Gly Gly Ser Gly Gly Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly
245 250 255 245 250 255
Gly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Gly Gly Gly SerGly Ser Glu Gly Gly Gly Ser Glu Gly Gly Gly Ser Gly Gly Gly Ser
260 265 270 260 265 270
Gly Ser Gly Asp Phe Asp Tyr Glu Lys Met Ala Asn Ala Asn Lys GlyGly Ser Gly Asp Phe Asp Tyr Glu Lys Met Ala Asn Ala Asn Lys Gly
275 280 285 275 280 285
Ala Met Thr Glu Asn Ala Asp Glu Asn Ala Leu Gln Ser Asp Ala LysAla Met Thr Glu Asn Ala Asp Glu Asn Ala Leu Gln Ser Asp Ala Lys
290 295 300 290 295 300
Gly Lys Leu Asp Ser Val Ala Thr Asp Tyr Gly Ala Ala Ile Asp GlyGly Lys Leu Asp Ser Val Ala Thr Asp Tyr Gly Ala Ala Ile Asp Gly
305 310 315 320305 310 315 320
Phe Ile Gly Asp Val Ser Gly Leu Ala Asn Gly Asn Gly Ala Thr GlyPhe Ile Gly Asp Val Ser Gly Leu Ala Asn Gly Asn Gly Ala Thr Gly
325 330 335 325 330 335
Asp Phe Ala Gly Ser Asn Ser Gln Met Ala Gln Val Gly Asp Gly AspAsp Phe Ala Gly Ser Asn Ser Gln Met Ala Gln Val Gly Asp Gly Asp
340 345 350 340 345 350
Asn Ser Pro Leu Met Asn Asn Phe Arg Gln Tyr Leu Pro Ser Leu ProAsn Ser Pro Leu Met Asn Asn Phe Arg Gln Tyr Leu Pro Ser Leu Pro
355 360 365 355 360 365
Gln Ser Val Glu Cys Arg Pro Tyr Val Phe Gly Ala Gly Lys Pro TyrGln Ser Val Glu Cys Arg Pro Tyr Val Phe Gly Ala Gly Lys Pro Tyr
370 375 380 370 375 380
Glu Phe Ser Ile Asp Cys Asp Lys Ile Asn Leu Phe Arg Gly Val PheGlu Phe Ser Ile Asp Cys Asp Lys Ile Asn Leu Phe Arg Gly Val Phe
385 390 395 400385 390 395 400
Ala Phe Leu Leu Tyr Val Ala Thr Phe Met Tyr Val Phe Ser Thr PheAla Phe Leu Leu Tyr Val Ala Thr Phe Met Tyr Val Phe Ser Thr Phe
405 410 415 405 410 415
Ala Asn Ile Leu Arg Asn Lys Glu SerAla Asn Ile Leu Arg Asn Lys Glu Ser
420 425 420 425
<210> 5<210> 5
<211> 62<211> 62
<212> PRT<212> PRT
<213> 人工设计<213> artificial design
<400> 5<400> 5
Trp His Leu Pro Tyr Asn Phe Glu Leu Ala Gln Arg Ala Glu Gly AspTrp His Leu Pro Tyr Asn Phe Glu Leu Ala Gln Arg Ala Glu Gly Asp
1 5 10 151 5 10 15
Asp Pro Ala Lys Ala Ala Phe Asp Ser Leu Gln Ala Ser Ala Thr GluAsp Pro Ala Lys Ala Ala Phe Asp Ser Leu Gln Ala Ser Ala Thr Glu
20 25 30 20 25 30
Tyr Ile Gly Tyr Ala Trp Ala Met Val Val Val Ile Val Gly Ala ThrTyr Ile Gly Tyr Ala Trp Ala Met Val Val Val Ile Val Gly Ala Thr
35 40 45 35 40 45
Ile Gly Ile Lys Leu Phe Lys Lys Phe Thr Ser Lys Ala SerIle Gly Ile Lys Leu Phe Lys Lys Phe Thr Ser Lys Ala Ser
50 55 60 50 55 60
<210> 6<210> 6
<211> 9206<211> 9206
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 6<400> 6
aacgctacta ccattagtag aattgatgcc accttttcag ctcgcgcccc aaatgaaaat 60aacgctacta ccttagtag aattgatgcc accttttcag ctcgcgcccc aaatgaaaat 60
atagctaaac aggttattga ccatttgcga aatgtatcta atggtcaaac taaatctact 120atagctaaac aggttatga ccatttgcga aatgtatcta atggtcaaac taaatctact 120
cgttcgcaga attgggaatc aactgttaca tggaatgaaa cttccagaca ccgtacttta 180cgttcgcaga attgggaatc aactgttaca tggaatgaaa cttccagaca ccgtacttta 180
gttgcatatt taaaacatgt tgaactacag caccagattc agcaattaag ctctaagcca 240gttgcatatt taaaacatgt tgaactacag caccagattc agcaattaag ctctaagcca 240
tccgcaaaaa tgacctctta tcaaaaggag caattaaagg tactgtctaa tcctgacctg 300tccgcaaaaa tgacctctta tcaaaaggag caattaaagg tactgtctaa tcctgacctg 300
ttggaatttg cttccggtct ggttcgcttt gaggctcgaa ttgaaacgcg atatttgaag 360ttggaatttg cttccggtct ggttcgcttt gaggctcgaa ttgaaacgcg atatttgaag 360
tctttcgggc ttcctcttaa tctttttgat gcaattcgct ttgcttctga ctataataga 420tctttcgggc ttcctcttaa tctttttgat gcaattcgct ttgcttctga ctataataga 420
cagggtaaag acctgatttt tgatttatgg tcattctcgt tttctgaact gtttaaagca 480cagggtaaag acctgatttt tgattatgg tcattctcgt tttctgaact gtttaaagca 480
tttgaggggg attcaatgaa tatttatgac gattccgcag tattggacgc tatccagtct 540tttgagggggg attcaatgaa tatttatgac gattccgcag tatggacgc tatccagtct 540
aaacatttta caattacccc ctctggcaaa acttcctttg caaaagcctc tcgctatttt 600aaacatttta caattaccccc ctctggcaaa acttcctttg caaaagcctc tcgctatttt 600
ggtttctatc gtcgtctggt taatgagggt tatgatagtg ttgctcttac catgcctcgt 660ggtttctatc gtcgtctggt taatgagggt tatgatagtg ttgctcttac catgcctcgt 660
aattcctttt ggcgttatgt atctgcatta gttgagtgtg gtattcctaa atctcaattg 720aattcctttt ggcgttatgt atctgcatta gttgagtgtg gtattcctaa atctcaattg 720
atgaatcttt ccacctgtaa taatgttgtt ccgttagttc gttttattaa cgtagatttt 780atgaatcttt ccacctgtaa taatgttgtt ccgttagttc gttttattaa cgtagatttt 780
tcctcccaac gtcctgactg gtataatgag ccagttctta aaatcgcata aggtaattca 840tcctcccaac gtcctgactg gtataatgag ccagttctta aaatcgcata aggtaattca 840
aaatgattaa agttgaaatt aaaccgtctc aagcgcaatt tactacccgt tctggtgttt 900aaatgattaa agttgaaatt aaaccgtctc aagcgcaatt tactacccgt tctggtgttt 900
ctcgtcaggg caagccttat tcactgaatg agcagctttg ttacgttgat ttgggtaatg 960ctcgtcaggg caagccttat tcactgaatg agcagctttg ttacgttgat ttgggtaatg 960
aatatccggt gcttgtcaag attactctcg acgaaggtca gccagcgtat gcgcctggtc 1020aatatccggt gcttgtcaag attackctcg acgaaggtca gccagcgtat gcgcctggtc 1020
tgtacaccgt gcatctgtcc tcgttcaaag ttggtcagtt cggttctctt atgattgacc 1080tgtacaccgt gcatctgtcc tcgttcaaag ttggtcagtt cggttctctt atgattgacc 1080
gtctgcgcct cgttccggct aagtaacatg gagcaggtcg cggatttcga cacaatttat 1140gtctgcgcct cgttccggct aagtaacatg gagcaggtcg cggatttcga cacaatttat 1140
caggcgatga tacaaatctc cgttgtactt tgtttcgcgc ttggtataat cgctgggggt 1200caggcgatga tacaaatctc cgttgtactt tgtttcgcgc ttggtataat cgctgggggt 1200
caaagatgag tgttttagtg tattctttcg cctctttcgt tttaggttgg tgccttcgta 1260caaagatgag tgttttagtg tattctttcg cctctttcgt tttaggttgg tgccttcgta 1260
gtggcattac gtattttacc cgtttaatgg aaacttcctc atgaaaaagt ctttagtcct 1320gtggcattac gtattttacc cgtttaatgg aaacttcctc atgaaaaagt ctttagtcct 1320
caaagcctcc gtagccgttg ctaccctcgt tccgatgctg tctttcgctg ctgagggtga 1380caaagcctcc gtagccgttg ctaccctcgt tccgatgctg tctttcgctg ctgagggtga 1380
cgatcccgca aaagcggcct ttgactccct gcaagcctca gcgaccgaat atatcggtta 1440cgatcccgca aaagcggcct ttgactccct gcaagcctca gcgaccgaat atatcggtta 1440
tgcgtgggcg atggttgttg tcattgtcgg cgcaactatc ggtatcaagc tgtttaagaa 1500tgcgtgggcg atggttgttg tcattgtcgg cgcaactatc ggtatcaagc tgtttaagaa 1500
attcacctcg aaagcaagct gataaaccga tacaattaaa ggctcctttt ggagcctttt 1560attcacctcg aaagcaagct gataaaccga tacaattaaa ggctcctttt ggagcctttt 1560
tttttggaga ttttcaacgt gaaaaaatta ttattcgcaa ttcctttagt tgttcctttc 1620tttttggaga ttttcaacgt gaaaaaatta ttattcgcaa ttcctttagt tgttcctttc 1620
tattctcact cggccgacgt ggcctggcct ctggggccga aactgttgaa agttgtttag 1680tattctcact cggccgacgt ggcctggcct ctggggccga aactgttgaa agttgtttag 1680
caaaacctca tacagaaaat tcatttacta acgtctggaa agacgacaaa actttagatc 1740caaaacctca tacagaaaat tcatttacta acgtctggaa agacgacaaa actttagatc 1740
gttacgctaa ctatgagggc tgtctgtgga atgctacagg cgttgtggtt tgtactggtg 1800gttacgctaa ctatgagggc tgtctgtgga atgctacagg cgttgtggtt tgtactggtg 1800
acgaaactca gtgttacggt acatgggttc ctattgggct tgctatccct gaaaatgagg 1860acgaaactca gtgttacggt acatgggttc ctattgggct tgctatccct gaaaatgagg 1860
gtggtggctc tgagggtggc ggttctgagg gtggcggttc tgagggtggc ggtactaaac 1920gtggtggctc tgagggtggc ggttctgagg gtggcggttc tgagggtggc ggtactaaac 1920
ctcctgagta cggtgataca cctattccgg gctatactta tatcaaccct ctcgacggca 1980ctcctgagta cggtgataca cctattccgg gctatactta tatcaaccct ctcgacggca 1980
cttatccgcc tggtactgag caaaaccccg ctaatcctaa tccttctctt gaggagtctc 2040cttatccgcc tggtactgag caaaaccccg ctaatcctaa tccttctctt gaggagtctc 2040
agcctcttaa tactttcatg tttcagaata ataggttccg aaataggcag ggtgcattaa 2100agcctcttaa tactttcatg tttcagaata ataggttccg aaataggcag ggtgcattaa 2100
ctgtttatac gggcactgtt actcaaggca ctgaccccgt taaaacttat taccagtaca 2160ctgtttatac gggcactgtt actcaaggca ctgaccccgt taaaacttat taccagtaca 2160
ctcctgtatc atcaaaagcc atgtatgacg cttactggaa cggtaaattc agagactgcg 2220ctcctgtatc atcaaaagcc atgtatgacg cttactggaa cggtaaattc agagactgcg 2220
ctttccattc tggctttaat gaggatccat tcgtttgtga atatcaaggc caatcgtctg 2280ctttccattc tggctttaat gaggatccat tcgtttgtga atatcaaggc caatcgtctg 2280
acctgcctca acctcctgtc aatgctggcg gcggctctgg tggtggttct ggtggcggct 2340acctgcctca acctcctgtc aatgctggcg gcggctctgg tggtggttct ggtggcggct 2340
ctgagggtgg cggctctgag ggtggcggtt ctgagggtgg cggctctgag ggtggcggtt 2400ctgagggtgg cggctctgag ggtggcggtt ctgagggtgg cggctctgag ggtggcggtt 2400
ccggtggcgg ctccggttcc ggtgattttg attatgaaaa aatggcaaac gctaataagg 2460ccggtggcgg ctccggttcc ggtgattttg attatgaaaa aatggcaaac gctaataagg 2460
gggctatgac cgaaaatgcc gatgaaaacg cgctacagtc tgacgctaaa ggcaaacttg 2520gggctatgac cgaaaatgcc gatgaaaacg cgctacagtc tgacgctaaa ggcaaacttg 2520
attctgtcgc tactgattac ggtgctgcta tcgatggttt cattggtgac gtttccggcc 2580attctgtcgc tactgattac ggtgctgcta tcgatggttt cattggtgac gtttccggcc 2580
ttgctaatgg taatggtgct actggtgatt ttgctggctc taattcccaa atggctcaag 2640ttgctaatgg taatggtgct actggtgatt ttgctggctc taattcccaa atggctcaag 2640
tcggtgacgg tgataattca cctttaatga ataatttccg tcaatattta ccttctttgc 2700tcggtgacgg tgataattca cctttaatga ataatttccg tcaatatta ccttctttgc 2700
ctcagtcggt tgaatgtcgc ccttatgtct ttggcgctgg taaaccatat gaattttcta 2760ctcagtcggt tgaatgtcgc ccttatgtct ttggcgctgg taaaccatat gaattttcta 2760
ttgattgtga caaaataaac ttattccgtg gtgtctttgc gtttctttta tatgttgcca 2820ttgattgtga caaaataaac ttattccgtg gtgtctttgc gtttctttta tatgttgcca 2820
cctttatgta tgtattttcg acgtttgcta acatactgcg taataaggag tcttaatcat 2880cctttatgta tgtattttcg acgtttgcta acatactgcg taataaggag tcttaatcat 2880
gccagttctt ttgggtattc cgttattatt gcgtttcctc ggtttccttc tggtaacttt 2940gccagttctt ttgggtattc cgttattatt gcgtttcctc ggtttccttc tggtaacttt 2940
gttcggctat ctgcttactt tccttaaaaa gggcttcggt aagatagcta ttgctatttc 3000gttcggctat ctgcttactt tccttaaaaa gggcttcggt aagatagcta ttgctatttc 3000
attgtttctt gctcttatta ttgggcttaa ctcaattctt gtgggttatc tctctgatat 3060attgtttctt gctcttatta ttgggcttaa ctcaattctt gtgggttatc tctctgatat 3060
tagcgcacaa ttaccctctg attttgttca gggcgttcag ttaattctcc cgtctaatgc 3120tagcgcacaa ttaccctctg attttgttca gggcgttcag ttaattctcc cgtctaatgc 3120
gcttccctgt ttttatgtta ttctctctgt aaaggctgct attttcattt ttgacgttaa 3180gcttccctgt tttatgtta ttctctctgt aaaggctgct attttcattt ttgacgttaa 3180
acaaaaaatc gtttcttatt tggattggga taaataaata tggctgttta ttttgtaact 3240acaaaaaatc gtttcttatt tggattggga taaataaata tggctgttta ttttgtaact 3240
ggcaaattag gctctggaaa gacgctcgtt agcgttggta agattcagga taaaattgta 3300ggcaaattag gctctggaaa gacgctcgtt agcgttggta agattcagga taaaattgta 3300
gctgggtgca aaatagcaac taatcttgat ttaaggcttc aaaacctccc gcaagtcggg 3360gctgggtgca aaatagcaac taatcttgat ttaaggcttc aaaacctccc gcaagtcggg 3360
aggttcgcta aaacgcctcg cgttcttaga ataccggata agccttctat ttctgatttg 3420aggttcgcta aaacgcctcg cgttcttaga ataccggata agccttctat ttctgatttg 3420
cttgctattg gtcgtggtaa tgattcctac gacgaaaata aaaacggttt gcttgttctt 3480cttgctattg gtcgtggtaa tgattcctac gacgaaaata aaaacggttt gcttgttctt 3480
gatgaatgcg gtacttggtt taatacccgt tcatggaatg acaaggaaag acagccgatt 3540gatgaatgcg gtacttggtt taatacccgt tcatggaatg acaaggaaag acagccgatt 3540
attgattggt ttcttcatgc tcgtaaattg ggatgggata ttatttttct tgttcaggat 3600attgattggt ttcttcatgc tcgtaaattg ggatgggata ttaatttttct tgttcaggat 3600
ttatctattg ttgataaaca ggcgcgttct gcattagctg aacacgttgt ttattgtcgc 3660ttatctattg ttgataaaca ggcgcgttct gcattagctg aacacgttgt ttaattgtcgc 3660
cgtctggaca gaattacttt accctttgtc ggcactttat attctcttgt tactggctca 3720cgtctggaca gaattacttt accctttgtc ggcactttat attctcttgt tactggctca 3720
aaaatgcctc tgcctaaatt acatgttggt gttgttaaat atggtgattc tcaattaagc 3780aaaatgcctc tgcctaaatt acatgttggt gttgttaaat atggtgattc tcaattaagc 3780
cctactgttg agcgttggct ttatactggt aagaatttat ataacgcata tgacactaaa 3840cctactgttg agcgttggct ttatactggt aagaatttat ataacgcata tgacactaaa 3840
caggcttttt ccagtaatta tgattcaggt gtttattcat atttaacccc ttatttatca 3900caggcttttt ccagtaatta tgattcaggt gtttaattcat atttaaccccc ttattatca 3900
cacggtcggt atttcaaacc attaaattta ggtcagaaga tgaaattaac taaaatatat 3960cacggtcggt atttcaaacc attaaattta ggtcagaaga tgaaattaac taaaatatat 3960
ttgaaaaagt tttctcgcgt tctttgtctt gcgataggat ttgcatcagc atttacatat 4020ttgaaaaagt tttctcgcgt tctttgtctt gcgataggat ttgcatcagc atttacatat 4020
agttatataa cccaacctaa gccggaggtt aaaaaggtag tctctcagac ctatgatttt 4080agttatataa cccaacctaa gccggaggtt aaaaaggtag tctctcagac ctatgatttt 4080
gataaattca ctattgactc ttctcagcgt cttaatctaa gctatcgcta tgttttcaag 4140gataaattca ctattgactc ttctcagcgt cttaatctaa gctatcgcta tgttttcaag 4140
gattctaagg gaaaattaat taatagcgac gatttacaga agcaaggtta ttccatcaca 4200gattctaagg gaaaattaat taatagcgac gatttacaga agcaaggtta ttccatcaca 4200
tatattgatt tatgtactgt ttcaattaaa aaaggtaatt caaatgaaat tgttaaatgt 4260tatattgatt tatgtactgt ttcaattaaa aaaggtaatt caaatgaaat tgttaaatgt 4260
aattaatttt gttttcttga tgtttgtttc atcatcttct tttgctcaag taattgaaat 4320aattaatttt gttttcttga tgtttgtttc atcatcttct tttgctcaag taattgaaat 4320
gaataattcg cctctgcgcg atttcgtgac ttggtattca aagcaaacag gtgaatctgt 4380gaataattcg cctctgcgcg atttcgtgac ttggtattca aagcaaacag gtgaatctgt 4380
tattgtctca cctgatgtta aaggtacagt gactgtatat tcctctgacg ttaagcctga 4440tattgtctca cctgatgtta aaggtacagt gactgtatat tcctctgacg ttaagcctga 4440
aaatttacgc aatttcttta tctctgtttt acgtgctaat aattttgata tggttggctc 4500aaatttacgc aatttcttta tctctgtttt acgtgctaat aattttgata tggttggctc 4500
aattccttcc ataattcaga aatataaccc aaatagtcag gattatattg atgaattgcc 4560aattccttcc ataattcaga aatataaccc aaatagtcag gattatattg atgaattgcc 4560
atcatctgat attcaggaat atgatgataa ttccgctcct tctggtggtt tctttgttcc 4620atcatctgat attcaggaat atgatgataa ttccgctcct tctggtggtt tctttgttcc 4620
gcaaaatgat aatgttactc aaacatttaa aattaataac gttcgcgcaa aggatttaat 4680gcaaaatgat aatgttactc aaacatttaa aattaataac gttcgcgcaa aggatttaat 4680
aagggttgta gaattgtttg ttaaatctaa tacatctaaa tcctcaaatg tattatctgt 4740aagggttgta gaattgtttg ttaaatctaa tacatctaaa tcctcaaatg tattatctgt 4740
tgatggttct aacttattag tagttagcgc ccctaaagat attttagata accttccgca 4800tgatggttct aacttattag tagttagcgc ccctaaagat attttagata accttccgca 4800
atttctttct actgttgatt tgccaactga ccagatattg attgaaggat taattttcga 4860atttctttct actgttgatt tgccaactga ccagatattg attgaaggat taattttcga 4860
ggttcagcaa ggtgatgctt tagatttttc ctttgctgct ggctctcagc gcggcactgt 4920ggttcagcaa ggtgatgctt tagatttttc ctttgctgct ggctctcagc gcggcactgt 4920
tgctggtggt gttaatactg accgtctaac ctctgtttta tcttctgcgg gtggttcgtt 4980tgctggtggt gttaatactg accgtctaac ctctgtttta tcttctgcgg gtggttcgtt 4980
cggtattttt aacggcgatg ttttagggct atcagttcgc gcattaaaga ctaatagcca 5040cggtattttt aacggcgatg ttttagggct atcagttcgc gcattaaaga ctaatagcca 5040
ttcaaaaata ttgtctgtgc ctcgtattct tacgctttca ggtcagaagg gttctatttc 5100ttcaaaaata ttgtctgtgc ctcgtattct tacgctttca ggtcagaagg gttctatttc 5100
tgttggccag aatgtccctt ttattactgg tcgtgtaact ggtgaatctg ccaatgtaaa 5160tgttggccag aatgtccctt ttaattactgg tcgtgtaact ggtgaatctg ccaatgtaaa 5160
taatccattt cagacggttg agcgtcaaaa tgttggtatt tctatgagtg tttttcccgt 5220taatccattt cagacggttg agcgtcaaaa tgttggtatt tctatgagtg tttttcccgt 5220
tgcaatggct ggcggtaata ttgttttaga tataaccagt aaggccgata gtttgagttc 5280tgcaatggct ggcggtaata ttgttttaga tataaccagt aaggccgata gtttgagttc 5280
ttctactcag gcaagtgatg ttattactaa tcaaagaagt attgcgacaa cggttaattt 5340ttctactcag gcaagtgatg ttattactaa tcaaagaagt attgcgacaa cggttaattt 5340
gcgtgatggt cagactcttt tgctcggtgg cctcactgat tacaaaaaca cttctcaaga 5400gcgtgatggt cagactcttt tgctcggtgg cctcactgat tacaaaaaca cttctcaaga 5400
ttctggtgtg ccgttcctgt ctaaaatccc tttaatcggc ctcctgttta gctcccgttc 5460ttctggtgtg ccgttcctgt ctaaaatccc tttaatcggc ctcctgttta gctcccgttc 5460
tgattctaac gaggaaagca cgttgtacgt gctcgtcaaa gcaaccatag tacgcgccct 5520tgattctaac gaggaaagca cgttgtacgt gctcgtcaaa gcaaccatag tacgcgccct 5520
gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg cagcgtgacc gctacacttg 5580gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg cagcgtgacc gctacacttg 5580
ccagcgccct agcgcccgct cctttcgctt tcttcccttc ctttctcgcc acgttctccg 5640ccagcgccct agcgcccgct cctttcgctt tcttcccttc ctttctcgcc acgttctccg 5640
gctttccccg tcaagctcta aatcggggga tctcgggaaa agcgttggtg accaaaggtg 5700gctttccccg tcaagctcta aatcggggga tctcgggaaa agcgttggtg accaaaggtg 5700
ccttttatca tcactttaaa aataaaaaac aattactcag tgcctgttat aagcagcaat 5760ccttttatca tcactttaaa aataaaaaac aattactcag tgcctgttat aagcagcaat 5760
taattatgat tgatgcctac atcacaacaa aaactgattt aacaaatggt tggtctgcct 5820taattatgat tgatgcctac atcacaacaa aaactgattt aacaaatggt tggtctgcct 5820
tagaaagtat atttgaacat tatcttgatt atattattga taataataaa aaccttatcc 5880tagaaagtat atttgaacat tatcttgatt atattattga taataataaa aaccttatcc 5880
ctatccaaga agtgatgcct atcattggtt ggaatgaact tgaaaaaatt agccttgaat 5940ctatccaaga agtgatgcct atcattggtt ggaatgaact tgaaaaaatt agccttgaat 5940
acattactgg taaggtaaac gccattgtca gcaaattgat ccaagagaac caacttaaag 6000aactactgg taaggtaaac gccattgtca gcaaattgat ccaagagaac caacttaaag 6000
cttatgatga tgatgtgctt aaaaacttac tcaatggctg gtttatgcat atcgcaatac 6060cttatgatga tgatgtgctt aaaaacttac tcaatggctg gtttatgcat atcgcaatac 6060
atgcgaaaaa cctaaaagag cttgccgata aaaaaggcca atttattgct atttaccgcg 6120atgcgaaaaa cctaaaagag cttgccgata aaaaaggcca atttattgct atttaccgcg 6120
gctttttatt gagcttgaaa gataaataaa atagataggt tttatttgaa gctaaatctt 6180gctttttatt gagcttgaaa gataaataaa atagataggt tttatttgaa gctaaatctt 6180
ctttatcgta aaaaatgccc tcttgggtta tcaagagggt cattatattt cgcggaataa 6240ctttatcgta aaaaatgccc tcttggggtta tcaagagggt catttatattt cgcggaataa 6240
catcatttgg tgacgaaata actaagcact tgtctcctgt ttactcccct gagcttgagg 6300catcatttgg tgacgaaata actaagcact tgtctcctgt ttactcccct gagcttgagg 6300
ggttaacatg aaggtcatcg atagcaggat aataatacag taaaacgcta aaccaataat 6360ggttaacatg aaggtcatcg atagcaggat aataatacag taaaacgcta aaccaataat 6360
ccaaatccag ccatcccaaa ttggtagtga atgattataa ataacagcaa acagtaatgg 6420ccaaatccag ccatcccaaa ttggtagtga atgattataa ataacagcaa acagtaatgg 6420
gccaataaca ccggttgcat tggtaaggct caccaataat ccctgtaaag caccttgctg 6480gccaataaca ccggttgcat tggtaaggct caccaataat ccctgtaaag caccttgctg 6480
atgactcttt gtttggatag acatcactcc ctgtaatgca ggtaaagcga tcccaccacc 6540atgactcttt gtttggatag acatcactcc ctgtaatgca ggtaaagcga tcccaccacc 6540
agccaataaa attaaaacag ggaaaactaa ccaaccttca gatataaacg ctaaaaaggc 6600agccaataaa attaaaacag ggaaaactaa ccaaccttca gatataaacg ctaaaaaggc 6600
aaatgcacta ctatctgcaa taaatccgag cagtactgcc gttttttcgc cccatttagt 6660aaatgcacta ctatctgcaa taaatccgag cagtactgcc gttttttcgc cccattagt 6660
ggctattctt cctgccacaa aggcttggaa tactgagtgt aaaagaccaa gacccgctaa 6720ggctattctt cctgccacaa aggcttggaa tactgagtgt aaaagaccaa gacccgctaa 6720
tgaaaagcca accatcatgc tattccatcc aaaacgattt tcggtaaata gcacccacac 6780tgaaaagcca accatcatgc tattccatcc aaaacgattt tcggtaaata gcacccacac 6780
cgttgcggga atttggccta tcaattgcgc tgaaaaataa ataatcaaca aaatgggcat 6840cgttgcggga atttggccta tcaattgcgc tgaaaaataa ataatcaaca aaatgggcat 6840
cgttttaaat aaagtgatgt ataccgaatt cgattgcgtc tcaaccccta cttcggtatc 6900cgttttaaat aaagtgatgt ataccgaatt cgattgcgtc tcaacccccta cttcggtatc 6900
tgtattatca cgtgtatttt tggtttcacg gaaccaaaac ataaccacaa ggaaagtgac 6960tgtattatca cgtgtatttt tggtttcacg gaaccaaaac ataaccacaa ggaaagtgac 6960
aatatttagc aacgcagcga taaaaaaggg actatgcggt gaaatctctc ctgcaaaacc 7020aatatttagc aacgcagcga taaaaaaggg actatgcggt gaaatctctc ctgcaaaacc 7020
accaataata ggccccgcta ttaaaccaag cccaaaactt gcccctaacc aaccgaacca 7080accaataata ggccccgcta ttaaaccaag cccaaaactt gcccctaacc aaccgaacca 7080
cttcacgcgt tgagaagctg aggtggtatc ggcaatgacc gatgccgcga cagccccagt 7140cttcacgcgt tgagaagctg aggtggtatc ggcaatgacc gatgccgcga cagccccagt 7140
agctcctgtg atccctgaaa gcaaacggcc taaatacagc atccaaagcg cacttgaaaa 7200agctcctgtg atccctgaaa gcaaacggcc taaatacagc atccaaagcg cacttgaaaa 7200
agccagcaat aagtaatcca gcgatgcgcc tattaatgac aacaacagca ctgggcgccg 7260agccagcaat aagtaatcca gcgatgcgcc tattaatgac aacaacagca ctgggcgccg 7260
accaaatcgg tcagacattt ttccaagcca aggagcaaag ataacctgca ttaacgcata 7320accaaatcgg tcagacattt ttccaagcca aggagcaaag ataacctgca ttaacgcata 7320
aagtgcaagc aatacgccaa agtggttagc gatatcttcc gaagcaataa attcacgtaa 7380aagtgcaagc aatacgccaa agtggttagc gatatcttcc gaagcaataa attcacgtaa 7380
taacgttggc aagactggca tgataaggcc aatccccatg gcatcgagta acgtaattac 7440taacgttggc aagactggca tgataaggcc aatccccatg gcatcgagta acgtaattac 7440
caatgcgatc tttgtcgaac tattcatttc acttttctct atcactgata gggagtggta 7500caatgcgatc tttgtcgaac tattcatttc acttttctct atcactgata gggagtggta 7500
aaataactct atcaatgata gagtgtcaac aaaaattagg aattaatgat gtctagatta 7560aaataactct atcaatgata gagtgtcaac aaaaattagg aattaatgat gtctagatta 7560
gataaaagta aagtgattaa cagcgcatta gagctgctta atgaggtcgg aatcgaaggt 7620gataaaagta aagtgattaa cagcgcatta gagctgctta atgaggtcgg aatcgaaggt 7620
ttaacaaccc gtaaactcgc ccagaagcta ggtgtagagc agcctacatt gtattggcat 7680ttaacaaccc gtaaactcgc ccagaagcta ggtgtagagc agcctacatt gtattggcat 7680
gtaaaaaata agcgggcttt gctcgacgcc ttagccattg agatgttaga taggcaccat 7740gtaaaaaata agcgggcttt gctcgacgcc ttagccattg agatgttaga taggcaccat 7740
actcactttt gccctttaga aggggaaagc tggcaagatt ttttacgtaa taacgctaaa 7800actcactttt gccctttaga aggggaaagc tggcaagatt ttttacgtaa taacgctaaa 7800
agttttagat gtgctttact aagtcatcgc gatggagcaa aagtacattt aggtacacgg 7860agttttagat gtgctttact aagtcatcgc gatggagcaa aagtacattt aggtacacgg 7860
cctacagaaa aacagtatga aactctcgaa aatcaattag cctttttatg ccaacaaggt 7920cctacagaaa aacagtatga aactctcgaa aatcaattag cctttttatg ccaacaaggt 7920
ttttcactag agaatgcatt atatgcactc agcgctgtgg ggcattttac tttaggttgc 7980ttttcactag agaatgcatt atatgcactc agcgctgtgg ggcattttac tttaggttgc 7980
gtattggaag atcaagagca tcaagtcgct aaagaagaaa gggaaacacc tactactgat 8040gtattggaag atcaagagca tcaagtcgct aaagaagaaa gggaaacacc tactactgat 8040
agtatgccgc cattattacg acaagctatc gaattatttg atcaccaagg tgcagagcca 8100agtatgccgc cattattacg acaagctatc gaattatttg atcaccaagg tgcagagcca 8100
gccttcttat tcggccttga attgatcata tgcggattag aaaaacaact taaatgtgaa 8160gccttcttat tcggccttga attgatcata tgcggattag aaaaacaact taaatgtgaa 8160
agtgggtctt aaaagcagca taaccttttt ccgtgatggt aacttcacgg taaccaagat 8220agtgggtctt aaaagcagca taaccttttt ccgtgatggt aacttcacgg taaccaagat 8220
gtcgagttaa ccacccttta gattcataaa gcgaaaataa tgcggctcca acgtacccac 8280gtcgagttaa ccacccttta gattcataaa gcgaaaataa tgcggctcca acgtacccac 8280
ctaaatggaa acggcgttca ctccaatcta aacacgcaca acagatttta cgtgaatgtt 8340ctaaatggaa acggcgttca ctccaatcta aacacgcaca acagaatttta cgtgaatgtt 8340
tggaaggaac gtcaattccc atttcatgaa aatattgaat accacttaat gtgatcattg 8400tggaaggaac gtcaattccc atttcatgaa aatattgaat accacttaat gtgatcattg 8400
aaccattttc agtgatccat tgctgttgac aaagggaatc atagatccct ttagggttcc 8460aaccattttc agtgatccat tgctgttgac aaagggaatc atagatccct ttagggttcc 8460
gatttagtgc tttacggcac ctcgacctcc aaaaacttga tttgggtgat ggttcacgta 8520gatttagtgc tttacggcac ctcgacctcc aaaaacttga tttgggtgat ggttcacgta 8520
gtgggccatc gccctgatag acggtttttc gccctttgac gttggagtcc acgttcttta 8580gtgggccatc gccctgatag acggtttttc gccctttgac gttggagtcc acgttcttta 8580
atagtggact cttgttccaa actggaacaa cactcacaac taactcggcc tattcttttg 8640atagtggact cttgttccaa actggaacaa cactcacaac taactcggcc tattcttttg 8640
atttataagg atttttgtca ttttctgctt actggttaaa aaataagctg atttaacaaa 8700atttataagg atttttgtca ttttctgctt actggttaaa aaataagctg atttaacaaa 8700
tatttaacgc gaaatttaac aaaacattaa cgtttacaat ttaaatattt gcttatacaa 8760tattaacgc gaaatttaac aaaacattaa cgtttacaat ttaaatattt gcttatacaa 8760
tcatcctgtt tttggggctt ttctgattat caatcggggt acatatgatt gacatgctag 8820tcatcctgtt tttggggctt ttctgattat caatcggggt acatatgatt gacatgctag 8820
ttttacgatt accgttcatc gattctcttg tttgctccag actttcaggt aatgacctga 8880ttttacgatt accgttcatc gattctcttg tttgctccag actttcaggt aatgacctga 8880
tagcctttgt agacctctca aaaatagcta ccctctccgg catgaattta tcagctagaa 8940tagcctttgt agacctctca aaaatagcta ccctctccgg catgaattta tcagctagaa 8940
cggttgaata tcatattgac ggtgatttga ctgtctccgg cctttctcac ccgtttgaat 9000cggttgaata tcatattgac ggtgatttga ctgtctccgg cctttctcac ccgtttgaat 9000
ctttgcctac tcattactcc ggcattgcat ttaaaatata tgagggttct aaaaattttt 9060ctttgcctac tcattactcc ggcattgcat ttaaaatata tgagggttct aaaaattttt 9060
atccctgcgt tgaaattaag gcttcaccag caaaagtatt acagggtcat aatgtttttg 9120atccctgcgt tgaaattaag gcttcaccag caaaagtatt acagggtcat aatgtttttg 9120
gtacaaccga tttagcttta tgctctgagg ctttattgct taattttgct aactctctgc 9180gtacaaccga tttagcttta tgctctgagg ctttattgct taattttgct aactctctgc 9180
cttgcttgta cgatttattg gatgtt 9206cttgcttgta cgattattg gatgtt 9206
<210> 7<210> 7
<211> 9234<211> 9234
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 7<400> 7
aacgctacta ccattagtag aattgatgcc accttttcag ctcgcgcccc aaatgaaaat 60aacgctacta ccttagtag aattgatgcc accttttcag ctcgcgcccc aaatgaaaat 60
atagctaaac aggttattga ccatttgcga aatgtatcta atggtcaaac taaatctact 120atagctaaac aggttatga ccatttgcga aatgtatcta atggtcaaac taaatctact 120
cgttcgcaga attgggaatc aactgttaca tggaatgaaa cttccagaca ccgtacttta 180cgttcgcaga attgggaatc aactgttaca tggaatgaaa cttccagaca ccgtacttta 180
gttgcatatt taaaacatgt tgaactacag caccagattc agcaattaag ctctaagcca 240gttgcatatt taaaacatgt tgaactacag caccagattc agcaattaag ctctaagcca 240
tccgcaaaaa tgacctctta tcaaaaggag caattaaagg tactgtctaa tcctgacctg 300tccgcaaaaa tgacctctta tcaaaaggag caattaaagg tactgtctaa tcctgacctg 300
ttggaatttg cttccggtct ggttcgcttt gaggctcgaa ttgaaacgcg atatttgaag 360ttggaatttg cttccggtct ggttcgcttt gaggctcgaa ttgaaacgcg atatttgaag 360
tctttcgggc ttcctcttaa tctttttgat gcaattcgct ttgcttctga ctataataga 420tctttcgggc ttcctcttaa tctttttgat gcaattcgct ttgcttctga ctataataga 420
cagggtaaag acctgatttt tgatttatgg tcattctcgt tttctgaact gtttaaagca 480cagggtaaag acctgatttt tgattatgg tcattctcgt tttctgaact gtttaaagca 480
tttgaggggg attcaatgaa tatttatgac gattccgcag tattggacgc tatccagtct 540tttgagggggg attcaatgaa tatttatgac gattccgcag tatggacgc tatccagtct 540
aaacatttta caattacccc ctctggcaaa acttcctttg caaaagcctc tcgctatttt 600aaacatttta caattaccccc ctctggcaaa acttcctttg caaaagcctc tcgctatttt 600
ggtttctatc gtcgtctggt taatgagggt tatgatagtg ttgctcttac catgcctcgt 660ggtttctatc gtcgtctggt taatgagggt tatgatagtg ttgctcttac catgcctcgt 660
aattcctttt ggcgttatgt atctgcatta gttgagtgtg gtattcctaa atctcaattg 720aattcctttt ggcgttatgt atctgcatta gttgagtgtg gtattcctaa atctcaattg 720
atgaatcttt ccacctgtaa taatgttgtt ccgttagttc gttttattaa cgtagatttt 780atgaatcttt ccacctgtaa taatgttgtt ccgttagttc gttttattaa cgtagatttt 780
tcctcccaac gtcctgactg gtataatgag ccagttctta aaatcgcata aggtaattca 840tcctcccaac gtcctgactg gtataatgag ccagttctta aaatcgcata aggtaattca 840
aaatgattaa agttgaaatt aaaccgtctc aagcgcaatt tactacccgt tctggtgttt 900aaatgattaa agttgaaatt aaaccgtctc aagcgcaatt tactacccgt tctggtgttt 900
ctcgtcaggg caagccttat tcactgaatg agcagctttg ttacgttgat ttgggtaatg 960ctcgtcaggg caagccttat tcactgaatg agcagctttg ttacgttgat ttgggtaatg 960
aatatccggt gcttgtcaag attactctcg acgaaggtca gccagcgtat gcgcctggtc 1020aatatccggt gcttgtcaag attackctcg acgaaggtca gccagcgtat gcgcctggtc 1020
tgtacaccgt gcatctgtcc tcgttcaaag ttggtcagtt cggttctctt atgattgacc 1080tgtacaccgt gcatctgtcc tcgttcaaag ttggtcagtt cggttctctt atgattgacc 1080
gtctgcgcct cgttccggct aagtaacatg gagcaggtcg cggatttcga cacaatttat 1140gtctgcgcct cgttccggct aagtaacatg gagcaggtcg cggatttcga cacaatttat 1140
caggcgatga tacaaatctc cgttgtactt tgtttcgcgc ttggtataat cgctgggggt 1200caggcgatga tacaaatctc cgttgtactt tgtttcgcgc ttggtataat cgctgggggt 1200
caaagatgag tgttttagtg tattctttcg cctctttcgt tttaggttgg tgccttcgta 1260caaagatgag tgttttagtg tattctttcg cctctttcgt tttaggttgg tgccttcgta 1260
gtggcattac gtattttacc cgtttaatgg aaacttcctc atgaaaaagt ctttagtcct 1320gtggcattac gtattttacc cgtttaatgg aaacttcctc atgaaaaagt ctttagtcct 1320
caaagcctcc gtagccgttg ctaccctcgt tccgatgctg tctttcgctg ctgagggtga 1380caaagcctcc gtagccgttg ctaccctcgt tccgatgctg tctttcgctg ctgagggtga 1380
cgatcccgca aaagcggcct ttgactccct gcaagcctca gcgaccgaat atatcggtta 1440cgatcccgca aaagcggcct ttgactccct gcaagcctca gcgaccgaat atatcggtta 1440
tgcgtgggcg atggttgttg tcattgtcgg cgcaactatc ggtatcaagc tgtttaagaa 1500tgcgtgggcg atggttgttg tcattgtcgg cgcaactatc ggtatcaagc tgtttaagaa 1500
attcacctcg aaagcaagct gataaaccga tacaattaaa ggctcctttt ggagcctttt 1560attcacctcg aaagcaagct gataaaccga tacaattaaa ggctcctttt ggagcctttt 1560
tttttggaga ttttcaacgt gaaaaaatta ttattcgcaa ttcctttagt tgttcctttc 1620tttttggaga ttttcaacgt gaaaaaatta ttattcgcaa ttcctttagt tgttcctttc 1620
tattctcact ccgctgaaac tgttgaaagt tgtttagcaa aacctcatac agaaaattca 1680tattctcact ccgctgaaac tgttgaaagt tgtttagcaa aacctcatac agaaaattca 1680
tttactaacg tctggaaaga cgacaaaact ttagatcgtt acgctaacta tgagggctgt 1740tttactaacg tctggaaaga cgacaaaact ttagatcgtt acgctaacta tgagggctgt 1740
ctgtggaatg ctacaggcgt tgtggtttgt actggtgacg aaactcagtg ttacggtaca 1800ctgtggaatg ctacaggcgt tgtggtttgt actggtgacg aaactcagtg ttacggtaca 1800
tgggttccta ttgggcttgc tatccctgaa aatgagggtg gtggctctga gggtggcggt 1860tgggttccta ttgggcttgc tatccctgaa aatgagggtg gtggctctga gggtggcggt 1860
tctgagggtg gcggttctga gggtggcggt actaaacctc ctgagtacgg tgatacacct 1920tctgagggtg gcggttctga gggtggcggt actaaacctc ctgagtacgg tgatacacct 1920
attccgggct atacttatat caaccctctc gacggcactt atccgcctgg tactgagcaa 1980attccgggct atacttatat caaccctctc gacggcactt atccgcctgg tactgagcaa 1980
aaccccgcta atcctaatcc ttctcttgag gagtctcagc ctcttaatac tttcatgttt 2040aaccccgcta atcctaatcc ttctcttgag gagtctcagc ctcttaatac tttcatgttt 2040
cagaataata ggttccgaaa taggcagggt gcattaactg tttatacggg cactgttact 2100cagaataata ggttccgaaa taggcagggt gcattaactg tttatacggg cactgttact 2100
caaggcactg accccgttaa aacttattac cagtacactc ctgtatcatc aaaagccatg 2160caaggcactg accccgttaa aacttattac cagtacactc ctgtatcatc aaaagccatg 2160
tatgacgctt actggaacgg taaattcaga gactgcgctt tccattctgg ctttaatgag 2220tatgacgctt actggaacgg taaattcaga gactgcgctt tccattctgg ctttaatgag 2220
gatccattcg tttgtgaata tcaaggccaa tcgtctgacc tgcctcaacc tcctgtcaat 2280gatccattcg tttgtgaata tcaaggccaa tcgtctgacc tgcctcaacc tcctgtcaat 2280
gctggcggcg gctctggtgg tggttctggt ggcggctctg agggtggcgg ctctgagggt 2340gctggcggcg gctctggtgg tggttctggt ggcggctctg agggtggcgg ctctgagggt 2340
ggcggttctg agggtggcgg ctctgagggt ggcggttccg gtggcggctc cggttccggt 2400ggcggttctg agggtggcgg ctctgagggt ggcggttccg gtggcggctc cggttccggt 2400
gattttgatt atgaaaaaat ggcaaacgct aataaggggg ctatgaccga aaatgccgat 2460gattttgatt atgaaaaaat ggcaaacgct aataaggggg ctatgaccga aaatgccgat 2460
gaaaacgcgc tacagtctga cgctaaaggc aaacttgatt ctgtcgctac tgattacggt 2520gaaaacgcgc tacagtctga cgctaaaggc aaacttgatt ctgtcgctac tgattacggt 2520
gctgctatcg atggtttcat tggtgacgtt tccggccttg ctaatggtaa tggtgctact 2580gctgctatcg atggtttcat tggtgacgtt tccggccttg ctaatggtaa tggtgctact 2580
ggtgattttg ctggctctaa ttcccaaatg gctcaagtcg gtgacggtga taattcacct 2640ggtgattttg ctggctctaa ttcccaaatg gctcaagtcg gtgacggtga taattcacct 2640
ttaatgaata atttccgtca atatttacct tctttgcctc agtcggttga atgtcgccct 2700ttaatgaata atttccgtca atatttacct tctttgcctc agtcggttga atgtcgccct 2700
tatgtctttg gcgctggtaa accatatgaa ttttctattg attgtgacaa aataaactta 2760tatgtctttg gcgctggtaa accatatgaa ttttctattg attgtgacaa aataaactta 2760
ttccgtggtg tctttgcgtt tcttttatat gttgccacct ttatgtatgt attttcgacg 2820ttccgtggtg tctttgcgtt tcttttatat gttgccacct ttatgtatgt attttcgacg 2820
tttgctaaca tactgcgtaa taaggagtct taatcatgcc agttcttttg ggtattccgt 2880tttgctaaca tactgcgtaa taaggagtct taatcatgcc agttcttttg ggtattccgt 2880
tattattgcg tttcctcggt ttccttctgg taactttgtt cggctatctg cttactttcc 2940tattattgcg tttcctcggt ttccttctgg taactttgtt cggctatctg cttactttcc 2940
ttaaaaaggg cttcggtaag atagctattg ctatttcatt gtttcttgct cttattattg 3000ttaaaaaggg cttcggtaag atagctattg ctatttcatt gtttcttgct cttattattg 3000
ggcttaactc aattcttgtg ggttatctct ctgatattag cgcacaatta ccctctgatt 3060ggcttaactc aattcttgtg ggttatctct ctgatattag cgcacaatta ccctctgatt 3060
ttgttcaggg cgttcagtta attctcccgt ctaatgcgct tccctgtttt tatgttattc 3120ttgttcaggg cgttcagtta attctcccgt ctaatgcgct tccctgtttt tatgttattc 3120
tctctgtaaa ggctgctatt ttcatttttg acgttaaaca aaaaatcgtt tcttatttgg 3180tctctgtaaa ggctgctatt ttcatttttg acgttaaaca aaaaatcgtt tcttatttgg 3180
attgggataa ataaatatgg ctgtttattt tgtaactggc aaattaggct ctggaaagac 3240attgggataa ataaatatgg ctgtttattt tgtaactggc aaattaggct ctggaaagac 3240
gctcgttagc gttggtaaga ttcaggataa aattgtagct gggtgcaaaa tagcaactaa 3300gctcgttagc gttggtaaga ttcaggataa aattgtagct gggtgcaaaa tagcaactaa 3300
tcttgattta aggcttcaaa acctcccgca agtcgggagg ttcgctaaaa cgcctcgcgt 3360tcttgatta aggcttcaaa acctcccgca agtcgggagg ttcgctaaaa cgcctcgcgt 3360
tcttagaata ccggataagc cttctatttc tgatttgctt gctattggtc gtggtaatga 3420tcttagaata ccggataagc cttctatttc tgatttgctt gctattggtc gtggtaatga 3420
ttcctacgac gaaaataaaa acggtttgct tgttcttgat gaatgcggta cttggtttaa 3480ttcctacgac gaaaataaaa acggtttgct tgttcttgat gaatgcggta cttggtttaa 3480
tacccgttca tggaatgaca aggaaagaca gccgattatt gattggtttc ttcatgctcg 3540tacccgttca tggaatgaca aggaaagaca gccgattatt gattggtttc ttcatgctcg 3540
taaattggga tgggatatta tttttcttgt tcaggattta tctattgttg ataaacaggc 3600taaattggga tgggatatta tttttcttgt tcaggattta tctattgttg ataaacaggc 3600
gcgttctgca ttagctgaac acgttgttta ttgtcgccgt ctggacagaa ttactttacc 3660gcgttctgca ttagctgaac acgttgttta ttgtcgccgt ctggacagaa ttactttacc 3660
ctttgtcggc actttatatt ctcttgttac tggctcaaaa atgcctctgc ctaaattaca 3720ctttgtcggc actttatatt ctcttgttac tggctcaaaa atgcctctgc ctaaattaca 3720
tgttggtgtt gttaaatatg gtgattctca attaagccct actgttgagc gttggcttta 3780tgttggtgtt gttaaatatg gtgattctca attaagccct actgttgagc gttggcttta 3780
tactggtaag aatttatata acgcatatga cactaaacag gctttttcca gtaattatga 3840tactggtaag aatttatata acgcatatga cactaaacag gctttttcca gtaattatga 3840
ttcaggtgtt tattcatatt taacccctta tttatcacac ggtcggtatt tcaaaccatt 3900ttcaggtgtt tattcatatt taacccctta tttatcacac ggtcggtatt tcaaaccatt 3900
aaatttaggt cagaagatga aattaactaa aatatatttg aaaaagtttt ctcgcgttct 3960aaatttaggt cagaagatga aattaactaa aatatatttg aaaaagtttt ctcgcgttct 3960
ttgtcttgcg ataggatttg catcagcatt tacatatagt tatataaccc aacctaagcc 4020ttgtcttgcg ataggatttg catcagcatt tacatatagt tatataaccc aacctaagcc 4020
ggaggttaaa aaggtagtct ctcagaccta tgattttgat aaattcacta ttgactcttc 4080ggaggttaaa aaggtagtct ctcagaccta tgattttgat aaattcacta ttgactcttc 4080
tcagcgtctt aatctaagct atcgctatgt tttcaaggat tctaagggaa aattaattaa 4140tcagcgtctt aatctaagct atcgctatgt tttcaaggat tctaagggaa aattaattaa 4140
tagcgacgat ttacagaagc aaggttattc catcacatat attgatttat gtactgtttc 4200tagcgacgat ttacagaagc aaggttattc catcacatat attgattat gtactgtttc 4200
aattaaaaaa ggtaattcaa atgaaattgt taaatgtaat taattttgtt ttcttgatgt 4260aattaaaaaa ggtaattcaa atgaaattgt taaatgtaat taattttgtt ttcttgatgt 4260
ttgtttcatc atcttctttt gctcaagtaa ttgaaatgaa taattcgcct ctgcgcgatt 4320ttgtttcatc atcttctttt gctcaagtaa ttgaaatgaa taattcgcct ctgcgcgatt 4320
tcgtgacttg gtattcaaag caaacaggtg aatctgttat tgtctcacct gatgttaaag 4380tcgtgacttg gtattcaaag caaacaggtg aatctgttat tgtctcacct gatgttaaag 4380
gtacagtgac tgtatattcc tctgacgtta agcctgaaaa tttacgcaat ttctttatct 4440gtacagtgac tgtatattcc tctgacgtta agcctgaaaa tttacgcaat ttctttatct 4440
ctgttttacg tgctaataat tttgatatgg ttggctcaat tccttccata attcagaaat 4500ctgttttacg tgctaataat tttgatatgg ttggctcaat tccttccata attcagaaat 4500
ataacccaaa tagtcaggat tatattgatg aattgccatc atctgatatt caggaatatg 4560ataacccaaa tagtcaggat tatattgatg aattgccatc atctgatatt caggaatatg 4560
atgataattc cgctccttct ggtggtttct ttgttccgca aaatgataat gttactcaaa 4620atgataattc cgctccttct ggtggtttct ttgttccgca aaatgataat gttactcaaa 4620
catttaaaat taataacgtt cgcgcaaagg atttaataag ggttgtagaa ttgtttgtta 4680catttaaaat taataacgtt cgcgcaaagg atttaataag ggttgtagaa ttgtttgtta 4680
aatctaatac atctaaatcc tcaaatgtat tatctgttga tggttctaac ttattagtag 4740aatctaatac atctaaatcc tcaaatgtat tatctgttga tggttctaac ttattagtag 4740
ttagcgcccc taaagatatt ttagataacc ttccgcaatt tctttctact gttgatttgc 4800ttagcgcccc taaagatatt ttagataacc ttccgcaatt tctttctact gttgatttgc 4800
caactgacca gatattgatt gaaggattaa ttttcgaggt tcagcaaggt gatgctttag 4860caactgacca gatattgatt gaaggattaa ttttcgaggt tcagcaaggt gatgctttag 4860
atttttcctt tgctgctggc tctcagcgcg gcactgttgc tggtggtgtt aatactgacc 4920attttcctt tgctgctggc tctcagcgcg gcactgttgc tggtggtgtt aatactgacc 4920
gtctaacctc tgttttatct tctgcgggtg gttcgttcgg tatttttaac ggcgatgttt 4980gtctaacctc tgttttatct tctgcgggtg gttcgttcgg tatttttaac ggcgatgttt 4980
tagggctatc agttcgcgca ttaaagacta atagccattc aaaaatattg tctgtgcctc 5040tagggctatc agttcgcgca ttaaagacta atagccattc aaaaatattg tctgtgcctc 5040
gtattcttac gctttcaggt cagaagggtt ctatttctgt tggccagaat gtccctttta 5100gtattcttac gctttcaggt cagaagggtt ctatttctgt tggccagaat gtccctttta 5100
ttactggtcg tgtaactggt gaatctgcca atgtaaataa tccatttcag acggttgagc 5160ttactggtcg tgtaactggt gaatctgcca atgtaaataa tccattcag acggttgagc 5160
gtcaaaatgt tggtatttct atgagtgttt ttcccgttgc aatggctggc ggtaatattg 5220gtcaaaatgt tggtatttct atgagtgttt ttcccgttgc aatggctggc ggtaatattg 5220
ttttagatat aaccagtaag gccgatagtt tgagttcttc tactcaggca agtgatgtta 5280ttttagatat aaccagtaag gccgatagtt tgagttcttc tactcaggca agtgatgtta 5280
ttactaatca aagaagtatt gcgacaacgg ttaatttgcg tgatggtcag actcttttgc 5340ttactaatca aagaagtatt gcgacaacgg ttaatttgcg tgatggtcag actcttttgc 5340
tcggtggcct cactgattac aaaaacactt ctcaagattc tggtgtgccg ttcctgtcta 5400tcggtggcct cactgattac aaaaacactt ctcaagattc tggtgtgccg ttcctgtcta 5400
aaatcccttt aatcggcctc ctgtttagct cccgttctga ttctaacgag gaaagcacgt 5460aaatcccttt aatcggcctc ctgtttagct cccgttctga ttctaacgag gaaagcacgt 5460
tgtacgtgct cgtcaaagca accatagtac gcgccctgta gcggcgcatt aagcgcggcg 5520tgtacgtgct cgtcaaagca accatagtac gcgccctgta gcggcgcatt aagcgcggcg 5520
ggtgtggtgg ttacgcgcag cgtgaccgct acacttgcca gcgccctagc gcccgctcct 5580ggtgtggtgg ttacgcgcag cgtgaccgct acacttgcca gcgccctagc gcccgctcct 5580
ttcgctttct tcccttcctt tctcgccacg ttctccggct ttccccgtca agctctaaat 5640ttcgctttct tcccttcctt tctcgccacg ttctccggct ttccccgtca agctctaaat 5640
cgggggagct cgagcttact ccccatcccc ctgttgacaa ttaatcatcg gctcgtataa 5700cggggggagct cgagcttact ccccatcccc ctgttgacaa ttaatcatcg gctcgtataa 5700
tgtgtggaat tgtgagcgga taacaatttc ttaatggaaa cttcctcatg aaaaagtctt 5760tgtgtggaat tgtgagcgga taacaatttc ttaatggaaa cttcctcatg aaaaagtctt 5760
tagttcttaa agcatctgtt gctgttgcga ctcttgttcc tatgctaagc tttgccaacg 5820tagttcttaa agcatctgtt gctgttgcga ctcttgttcc tatgctaagc tttgccaacg 5820
tccctgcaga aggtgatgac ccggctaaag ctgcttttga ctctcttcag gcttctgcta 5880tccctgcaga aggtgatgac ccggctaaag ctgcttttga ctctcttcag gcttctgcta 5880
ctgaatacat cggctacgct tgggctatgg tggttgttat cgttggtgct actattggca 5940ctgaatacat cggctacgct tgggctatgg tggttgttat cgttggtgct actattggca 5940
tcaaactttt caaaaaattc acttctaaag cgtcttaatg aactcagata cccagcccgc 6000tcaaactttt caaaaaattc acttctaaag cgtcttaatg aactcagata cccagcccgc 6000
ctaatgagcg ggcttttttt taagctagct tatgatgatg atgtgcttaa aaacttactc 6060ctaatgagcg ggcttttttt taagctagct tatgatgatg atgtgcttaa aaacttactc 6060
aatggctggt ttatgcatat cgcaatacat gcgaaaaacc taaaagagct tgccgataaa 6120aatggctggt ttatgcatat cgcaatacat gcgaaaaacc taaaagagct tgccgataaa 6120
aaaggccaat ttattgctat ttaccgcggc tttttattga gcttgaaaga taaataaaat 6180aaaggccaat ttattgctat ttaccgcggc tttttatga gcttgaaaga taaataaaat 6180
agataggttt tatttgaagc taaatcttct ttatcgtaaa aaatgccctc ttgggttatc 6240agataggttt tatttgaagc taaatcttct ttatcgtaaa aaatgccctc ttgggttatc 6240
aagagggtca ttatatttcg cggaataaca tcatttggtg acgaaataac taagcacttg 6300aagagggtca ttatatttcg cggaataaca tcatttggtg acgaaataac taagcacttg 6300
tctcctgttt actcccctga gcttgagggg ttaacatgaa ggtcatcgat agcaggataa 6360tctcctgttt actcccctga gcttgagggg ttaacatgaa ggtcatcgat agcaggataa 6360
taatacagta aaacgctaaa ccaataatcc aaatccagcc atcccaaatt ggtagtgaat 6420taatacagta aaacgctaaa ccaataatcc aaatccagcc atcccaaatt ggtagtgaat 6420
gattataaat aacagcaaac agtaatgggc caataacacc ggttgcattg gtaaggctca 6480gattataaat aacagcaaac agtaatgggc caataacacc ggttgcattg gtaaggctca 6480
ccaataatcc ctgtaaagca ccttgctgat gactctttgt ttggatagac atcactccct 6540ccaataatcc ctgtaaagca ccttgctgat gactctttgt ttggatagac atcactccct 6540
gtaatgcagg taaagcgatc ccaccaccag ccaataaaat taaaacaggg aaaactaacc 6600gtaatgcagg taaagcgatc ccaccaccag ccaataaaat taaaacaggg aaaactaacc 6600
aaccttcaga tataaacgct aaaaaggcaa atgcactact atctgcaata aatccgagca 6660aaccttcaga tataaacgct aaaaaggcaa atgcactact atctgcaata aatccgagca 6660
gtactgccgt tttttcgccc catttagtgg ctattcttcc tgccacaaag gcttggaata 6720gtactgccgt tttttcgccc catttagtgg ctattcttcc tgccacaaag gcttggaata 6720
ctgagtgtaa aagaccaaga cccgctaatg aaaagccaac catcatgcta ttccatccaa 6780ctgagtgtaa aagaccaaga cccgctaatg aaaagccaac catcatgcta ttccatccaa 6780
aacgattttc ggtaaatagc acccacaccg ttgcgggaat ttggcctatc aattgcgctg 6840aacgattttc ggtaaatagc accccacaccg ttgcgggaat ttggcctatc aattgcgctg 6840
aaaaataaat aatcaacaaa atgggcatcg ttttaaataa agtgatgtat accgaattcg 6900aaaaataaat aatcaacaaa atgggcatcg ttttaaataa agtgatgtat accgaattcg 6900
attgcgtctc aacccctact tcggtatctg tattatcacg tgtatttttg gtttcacgga 6960attgcgtctc aacccctact tcggtatctg tattatcacg tgtatttttg gtttcacgga 6960
accaaaacat aaccacaagg aaagtgacaa tatttagcaa cgcagcgata aaaaagggac 7020accaaaacat aaccacaagg aaagtgacaa tatttagcaa cgcagcgata aaaaagggac 7020
tatgcggtga aatctctcct gcaaaaccac caataatagg ccccgctatt aaaccaagcc 7080tatgcggtga aatctctcct gcaaaaccac caataatagg ccccgctatt aaaccaagcc 7080
caaaacttgc ccctaaccaa ccgaaccact tcacgcgttg agaagctgag gtggtatcgg 7140caaaacttgc ccctaaccaa ccgaaccact tcacgcgttg agaagctgag gtggtatcgg 7140
caatgaccga tgccgcgaca gccccagtag ctcctgtgat ccctgaaagc aaacggccta 7200caatgaccga tgccgcgaca gccccagtag ctcctgtgat ccctgaaagc aaacggccta 7200
aatacagcat ccaaagcgca cttgaaaaag ccagcaataa gtaatccagc gatgcgccta 7260aatacagcat ccaaagcgca cttgaaaaag ccagcaataa gtaatccagc gatgcgccta 7260
ttaatgacaa caacagcact gggcgccgac caaatcggtc agacattttt ccaagccaag 7320ttaatgacaa caacagcact gggcgccgac caaatcggtc agacattttt ccaagccaag 7320
gagcaaagat aacctgcatt aacgcataaa gtgcaagcaa tacgccaaag tggttagcga 7380gagcaaagat aacctgcatt aacgcataaa gtgcaagcaa tacgccaaag tggttagcga 7380
tatcttccga agcaataaat tcacgtaata acgttggcaa gactggcatg ataaggccaa 7440tatcttccga agcaataaat tcacgtaata acgttggcaa gactggcatg ataaggccaa 7440
tccccatggc atcgagtaac gtaattacca atgcgatctt tgtcgaacta ttcatttcac 7500tccccatggc atcgagtaac gtaattacca atgcgatctt tgtcgaacta ttcatttcac 7500
ttttctctat cactgatagg gagtggtaaa ataactctat caatgataga gtgtcaacaa 7560ttttctctat cactgatagg gagtggtaaa ataactctat caatgataga gtgtcaacaa 7560
aaattaggaa ttaatgatgt ctagattaga taaaagtaaa gtgattaaca gcgcattaga 7620aaattaggaa ttaatgatgt ctagattaga taaaagtaaa gtgattaaca gcgcattaga 7620
gctgcttaat gaggtcggaa tcgaaggttt aacaacccgt aaactcgccc agaagctagg 7680gctgcttaat gaggtcggaa tcgaaggttt aacaacccgt aaactcgccc agaagctagg 7680
tgtagagcag cctacattgt attggcatgt aaaaaataag cgggctttgc tcgacgcctt 7740tgtagagcag cctacattgt attggcatgt aaaaaataag cgggctttgc tcgacgcctt 7740
agccattgag atgttagata ggcaccatac tcacttttgc cctttagaag gggaaagctg 7800agccattgag atgttagata ggcaccatac tcacttttgc cctttagaag gggaaagctg 7800
gcaagatttt ttacgtaata acgctaaaag ttttagatgt gctttactaa gtcatcgcga 7860gcaagatttt ttacgtaata acgctaaaag ttttagatgt gctttactaa gtcatcgcga 7860
tggagcaaaa gtacatttag gtacacggcc tacagaaaaa cagtatgaaa ctctcgaaaa 7920tggagcaaaa gtacatttag gtacacggcc tacagaaaaa cagtatgaaa ctctcgaaaa 7920
tcaattagcc tttttatgcc aacaaggttt ttcactagag aatgcattat atgcactcag 7980tcaattagcc tttttatgcc aacaaggttt ttcactagag aatgcattat atgcactcag 7980
cgctgtgggg cattttactt taggttgcgt attggaagat caagagcatc aagtcgctaa 8040cgctgtgggg cattttactt taggttgcgt attggaagat caagagcatc aagtcgctaa 8040
agaagaaagg gaaacaccta ctactgatag tatgccgcca ttattacgac aagctatcga 8100agaagaaagg gaaacaccta ctactgatag tatgccgcca ttattacgac aagctatcga 8100
attatttgat caccaaggtg cagagccagc cttcttattc ggccttgaat tgatcatatg 8160attatttgat caccaaggtg cagagccagc cttcttattc ggccttgaat tgatcatatg 8160
cggattagaa aaacaactta aatgtgaaag tgggtcttaa aagcagcata acctttttcc 8220cggattagaa aaacaactta aatgtgaaag tgggtcttaa aagcagcata acctttttcc 8220
gtgatggtaa cttcacggta accaagatgt cgagttaacc accctttaga ttcataaagc 8280gtgatggtaa cttcacggta accaagatgt cgagttaacc accctttaga ttcataaagc 8280
gaaaataatg cggctccaac gtacccacct aaatggaaac ggcgttcact ccaatctaaa 8340gaaaataatg cggctccaac gtacccacct aaatggaaac ggcgttcact ccaatctaaa 8340
cacgcacaac agattttacg tgaatgtttg gaaggaacgt caattcccat ttcatgaaaa 8400cacgcacaac agattttacg tgaatgtttg gaaggaacgt caattcccat ttcatgaaaa 8400
tattgaatac cacttaatgt gatcattgaa ccattttcag tgatccattg ctgttgacaa 8460tattgaatac cacttaatgt gatcattgaa ccattttcag tgatccatg ctgttgacaa 8460
agggaatcat agatcccttt agggttccga tttagtgctt tacggcacct cgacctccaa 8520agggaatcat agatcccttt agggttccga tttagtgctt tacggcacct cgacctccaa 8520
aaacttgatt tgggtgatgg ttcacgtagt gggccatcgc cctgatagac ggtttttcgc 8580aaacttgatt tgggtgatgg ttcacgtagt gggccatcgc cctgatagac ggtttttcgc 8580
cctttgacgt tggagtccac gttctttaat agtggactct tgttccaaac tggaacaaca 8640cctttgacgt tggagtccac gttctttaat agtggactct tgttccaaac tggaacaaca 8640
ctcacaacta actcggccta ttcttttgat ttataaggat ttttgtcatt ttctgcttac 8700ctcacaacta actcggccta ttcttttgat ttataaggat ttttgtcatt ttctgcttac 8700
tggttaaaaa ataagctgat ttaacaaata tttaacgcga aatttaacaa aacattaacg 8760tggttaaaaa ataagctgat ttaacaaata tttaacgcga aatttaacaa aacattaacg 8760
tttacaattt aaatatttgc ttatacaatc atcctgtttt tggggctttt ctgattatca 8820tttacaattt aaatatttgc ttatacaatc atcctgtttt tggggctttt ctgattatca 8820
atcggggtac atatgattga catgctagtt ttacgattac cgttcatcga ttctcttgtt 8880atcggggtac atatgattga catgctagtt ttacgattac cgttcatcga ttctcttgtt 8880
tgctccagac tttcaggtaa tgacctgata gcctttgtag acctctcaaa aatagctacc 8940tgctccagac tttcaggtaa tgacctgata gcctttgtag acctctcaaa aatagctacc 8940
ctctccggca tgaatttatc agctagaacg gttgaatatc atattgacgg tgatttgact 9000ctctccggca tgaatttatc agctagaacg gttgaatatc atattgacgg tgatttgact 9000
gtctccggcc tttctcaccc gtttgaatct ttgcctactc attactccgg cattgcattt 9060gtctccggcc tttctcaccc gtttgaatct ttgcctactc attackccgg cattgcattt 9060
aaaatatatg agggttctaa aaatttttat ccctgcgttg aaattaaggc ttcaccagca 9120aaaatatatg agggttctaa aaatttttat ccctgcgttg aaattaaggc ttcaccagca 9120
aaagtattac agggtcataa tgtttttggt acaaccgatt tagctttatg ctctgaggct 9180aaagtattac agggtcataa tgtttttggt acaaccgatt tagctttatg ctctgaggct 9180
ttattgctta attttgctaa ctctctgcct tgcttgtacg atttattgga tgtt 9234ttattgctta attttgctaa ctctctgcct tgcttgtacg atttattgga tgtt 9234
<210> 8<210> 8
<211> 26<211> 26
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 8<400> 8
gccgacgtgg cccggcctct ggggcc 26gccgacgtgg cccggcctct ggggcc 26
<210> 9<210> 9
<211> 15<211> 15
<212> PRT<212> PRT
<213> 人工设计<213> artificial design
<400> 9<400> 9
Ala Arg Glu Tyr Gly Thr Arg Phe Ser Leu Ile Gly Gly Tyr ArgAla Arg Glu Tyr Gly Thr Arg Phe Ser Leu Ile Gly Gly Tyr Arg
1 5 10 151 5 10 15
<210> 10<210> 10
<211> 9257<211> 9257
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 10<400> 10
aacgctacta ccattagtag aattgatgcc accttttcag ctcgcgcccc aaatgaaaat 60aacgctacta ccttagtag aattgatgcc accttttcag ctcgcgcccc aaatgaaaat 60
atagctaaac aggttattga ccatttgcga aatgtatcta atggtcaaac taaatctact 120atagctaaac aggttatga ccatttgcga aatgtatcta atggtcaaac taaatctact 120
cgttcgcaga attgggaatc aactgttaca tggaatgaaa cttccagaca ccgtacttta 180cgttcgcaga attgggaatc aactgttaca tggaatgaaa cttccagaca ccgtacttta 180
gttgcatatt taaaacatgt tgaactacag caccagattc agcaattaag ctctaagcca 240gttgcatatt taaaacatgt tgaactacag caccagattc agcaattaag ctctaagcca 240
tccgcaaaaa tgacctctta tcaaaaggag caattaaagg tactgtctaa tcctgacctg 300tccgcaaaaa tgacctctta tcaaaaggag caattaaagg tactgtctaa tcctgacctg 300
ttggaatttg cttccggtct ggttcgcttt gaggctcgaa ttgaaacgcg atatttgaag 360ttggaatttg cttccggtct ggttcgcttt gaggctcgaa ttgaaacgcg atatttgaag 360
tctttcgggc ttcctcttaa tctttttgat gcaattcgct ttgcttctga ctataataga 420tctttcgggc ttcctcttaa tctttttgat gcaattcgct ttgcttctga ctataataga 420
cagggtaaag acctgatttt tgatttatgg tcattctcgt tttctgaact gtttaaagca 480cagggtaaag acctgatttt tgattatgg tcattctcgt tttctgaact gtttaaagca 480
tttgaggggg attcaatgaa tatttatgac gattccgcag tattggacgc tatccagtct 540tttgagggggg attcaatgaa tatttatgac gattccgcag tatggacgc tatccagtct 540
aaacatttta caattacccc ctctggcaaa acttcctttg caaaagcctc tcgctatttt 600aaacatttta caattaccccc ctctggcaaa acttcctttg caaaagcctc tcgctatttt 600
ggtttctatc gtcgtctggt taatgagggt tatgatagtg ttgctcttac catgcctcgt 660ggtttctatc gtcgtctggt taatgagggt tatgatagtg ttgctcttac catgcctcgt 660
aattcctttt ggcgttatgt atctgcatta gttgagtgtg gtattcctaa atctcaattg 720aattcctttt ggcgttatgt atctgcatta gttgagtgtg gtattcctaa atctcaattg 720
atgaatcttt ccacctgtaa taatgttgtt ccgttagttc gttttattaa cgtagatttt 780atgaatcttt ccacctgtaa taatgttgtt ccgttagttc gttttattaa cgtagatttt 780
tcctcccaac gtcctgactg gtataatgag ccagttctta aaatcgcata aggtaattca 840tcctcccaac gtcctgactg gtataatgag ccagttctta aaatcgcata aggtaattca 840
aaatgattaa agttgaaatt aaaccgtctc aagcgcaatt tactacccgt tctggtgttt 900aaatgattaa agttgaaatt aaaccgtctc aagcgcaatt tactacccgt tctggtgttt 900
ctcgtcaggg caagccttat tcactgaatg agcagctttg ttacgttgat ttgggtaatg 960ctcgtcaggg caagccttat tcactgaatg agcagctttg ttacgttgat ttgggtaatg 960
aatatccggt gcttgtcaag attactctcg acgaaggtca gccagcgtat gcgcctggtc 1020aatatccggt gcttgtcaag attackctcg acgaaggtca gccagcgtat gcgcctggtc 1020
tgtacaccgt gcatctgtcc tcgttcaaag ttggtcagtt cggttctctt atgattgacc 1080tgtacaccgt gcatctgtcc tcgttcaaag ttggtcagtt cggttctctt atgattgacc 1080
gtctgcgcct cgttccggct aagtaacatg gagcaggtcg cggatttcga cacaatttat 1140gtctgcgcct cgttccggct aagtaacatg gagcaggtcg cggatttcga cacaatttat 1140
caggcgatga tacaaatctc cgttgtactt tgtttcgcgc ttggtataat cgctgggggt 1200caggcgatga tacaaatctc cgttgtactt tgtttcgcgc ttggtataat cgctgggggt 1200
caaagatgag tgttttagtg tattctttcg cctctttcgt tttaggttgg tgccttcgta 1260caaagatgag tgttttagtg tattctttcg cctctttcgt tttaggttgg tgccttcgta 1260
gtggcattac gtattttacc cgtttaatgg aaacttcctc atgaaaaagt ctttagtcct 1320gtggcattac gtattttacc cgtttaatgg aaacttcctc atgaaaaagt ctttagtcct 1320
caaagcctcc gtagccgttg ctaccctcgt tccgatgctg tctttcgctg ctgagggtga 1380caaagcctcc gtagccgttg ctaccctcgt tccgatgctg tctttcgctg ctgagggtga 1380
cgatcccgca aaagcggcct ttgactccct gcaagcctca gcgaccgaat atatcggtta 1440cgatcccgca aaagcggcct ttgactccct gcaagcctca gcgaccgaat atatcggtta 1440
tgcgtgggcg atggttgttg tcattgtcgg cgcaactatc ggtatcaagc tgtttaagaa 1500tgcgtgggcg atggttgttg tcattgtcgg cgcaactatc ggtatcaagc tgtttaagaa 1500
attcacctcg aaagcaagct gataaaccga tacaattaaa ggctcctttt ggagcctttt 1560attcacctcg aaagcaagct gataaaccga tacaattaaa ggctcctttt ggagcctttt 1560
tttttggaga ttttcaacgt gaaaaaatta ttattcgcaa ttcctttagt tgttcctttc 1620tttttggaga ttttcaacgt gaaaaaatta ttattcgcaa ttcctttagt tgttcctttc 1620
tattctcact cggccgacgt ggcccggcct ctggggccga aactgttgaa agttgtttag 1680tattctcact cggccgacgt ggcccggcct ctggggccga aactgttgaa agttgtttag 1680
caaaacctca tacagaaaat tcatttacta acgtctggaa agacgacaaa actttagatc 1740caaaacctca tacagaaaat tcatttacta acgtctggaa agacgacaaa actttagatc 1740
gttacgctaa ctatgagggc tgtctgtgga atgctacagg cgttgtggtt tgtactggtg 1800gttacgctaa ctatgagggc tgtctgtgga atgctacagg cgttgtggtt tgtactggtg 1800
acgaaactca gtgttacggt acatgggttc ctattgggct tgctatccct gaaaatgagg 1860acgaaactca gtgttacggt acatgggttc ctattgggct tgctatccct gaaaatgagg 1860
gtggtggctc tgagggtggc ggttctgagg gtggcggttc tgagggtggc ggtactaaac 1920gtggtggctc tgagggtggc ggttctgagg gtggcggttc tgagggtggc ggtactaaac 1920
ctcctgagta cggtgataca cctattccgg gctatactta tatcaaccct ctcgacggca 1980ctcctgagta cggtgataca cctattccgg gctatactta tatcaaccct ctcgacggca 1980
cttatccgcc tggtactgag caaaaccccg ctaatcctaa tccttctctt gaggagtctc 2040cttatccgcc tggtactgag caaaaccccg ctaatcctaa tccttctctt gaggagtctc 2040
agcctcttaa tactttcatg tttcagaata ataggttccg aaataggcag ggtgcattaa 2100agcctcttaa tactttcatg tttcagaata ataggttccg aaataggcag ggtgcattaa 2100
ctgtttatac gggcactgtt actcaaggca ctgaccccgt taaaacttat taccagtaca 2160ctgtttatac gggcactgtt actcaaggca ctgaccccgt taaaacttat taccagtaca 2160
ctcctgtatc atcaaaagcc atgtatgacg cttactggaa cggtaaattc agagactgcg 2220ctcctgtatc atcaaaagcc atgtatgacg cttactggaa cggtaaattc agagactgcg 2220
ctttccattc tggctttaat gaggatccat tcgtttgtga atatcaaggc caatcgtctg 2280ctttccattc tggctttaat gaggatccat tcgtttgtga atatcaaggc caatcgtctg 2280
acctgcctca acctcctgtc aatgctggcg gcggctctgg tggtggttct ggtggcggct 2340acctgcctca acctcctgtc aatgctggcg gcggctctgg tggtggttct ggtggcggct 2340
ctgagggtgg cggctctgag ggtggcggtt ctgagggtgg cggctctgag ggtggcggtt 2400ctgagggtgg cggctctgag ggtggcggtt ctgagggtgg cggctctgag ggtggcggtt 2400
ccggtggcgg ctccggttcc ggtgattttg attatgaaaa aatggcaaac gctaataagg 2460ccggtggcgg ctccggttcc ggtgattttg attatgaaaa aatggcaaac gctaataagg 2460
gggctatgac cgaaaatgcc gatgaaaacg cgctacagtc tgacgctaaa ggcaaacttg 2520gggctatgac cgaaaatgcc gatgaaaacg cgctacagtc tgacgctaaa ggcaaacttg 2520
attctgtcgc tactgattac ggtgctgcta tcgatggttt cattggtgac gtttccggcc 2580attctgtcgc tactgattac ggtgctgcta tcgatggttt cattggtgac gtttccggcc 2580
ttgctaatgg taatggtgct actggtgatt ttgctggctc taattcccaa atggctcaag 2640ttgctaatgg taatggtgct actggtgatt ttgctggctc taattcccaa atggctcaag 2640
tcggtgacgg tgataattca cctttaatga ataatttccg tcaatattta ccttctttgc 2700tcggtgacgg tgataattca cctttaatga ataatttccg tcaatatta ccttctttgc 2700
ctcagtcggt tgaatgtcgc ccttatgtct ttggcgctgg taaaccatat gaattttcta 2760ctcagtcggt tgaatgtcgc ccttatgtct ttggcgctgg taaaccatat gaattttcta 2760
ttgattgtga caaaataaac ttattccgtg gtgtctttgc gtttctttta tatgttgcca 2820ttgattgtga caaaataaac ttattccgtg gtgtctttgc gtttctttta tatgttgcca 2820
cctttatgta tgtattttcg acgtttgcta acatactgcg taataaggag tcttaatcat 2880cctttatgta tgtattttcg acgtttgcta acatactgcg taataaggag tcttaatcat 2880
gccagttctt ttgggtattc cgttattatt gcgtttcctc ggtttccttc tggtaacttt 2940gccagttctt ttgggtattc cgttattatt gcgtttcctc ggtttccttc tggtaacttt 2940
gttcggctat ctgcttactt tccttaaaaa gggcttcggt aagatagcta ttgctatttc 3000gttcggctat ctgcttactt tccttaaaaa gggcttcggt aagatagcta ttgctatttc 3000
attgtttctt gctcttatta ttgggcttaa ctcaattctt gtgggttatc tctctgatat 3060attgtttctt gctcttatta ttgggcttaa ctcaattctt gtgggttatc tctctgatat 3060
tagcgcacaa ttaccctctg attttgttca gggcgttcag ttaattctcc cgtctaatgc 3120tagcgcacaa ttaccctctg attttgttca gggcgttcag ttaattctcc cgtctaatgc 3120
gcttccctgt ttttatgtta ttctctctgt aaaggctgct attttcattt ttgacgttaa 3180gcttccctgt tttatgtta ttctctctgt aaaggctgct attttcattt ttgacgttaa 3180
acaaaaaatc gtttcttatt tggattggga taaataaata tggctgttta ttttgtaact 3240acaaaaaatc gtttcttatt tggattggga taaataaata tggctgttta ttttgtaact 3240
ggcaaattag gctctggaaa gacgctcgtt agcgttggta agattcagga taaaattgta 3300ggcaaattag gctctggaaa gacgctcgtt agcgttggta agattcagga taaaattgta 3300
gctgggtgca aaatagcaac taatcttgat ttaaggcttc aaaacctccc gcaagtcggg 3360gctgggtgca aaatagcaac taatcttgat ttaaggcttc aaaacctccc gcaagtcggg 3360
aggttcgcta aaacgcctcg cgttcttaga ataccggata agccttctat ttctgatttg 3420aggttcgcta aaacgcctcg cgttcttaga ataccggata agccttctat ttctgatttg 3420
cttgctattg gtcgtggtaa tgattcctac gacgaaaata aaaacggttt gcttgttctt 3480cttgctattg gtcgtggtaa tgattcctac gacgaaaata aaaacggttt gcttgttctt 3480
gatgaatgcg gtacttggtt taatacccgt tcatggaatg acaaggaaag acagccgatt 3540gatgaatgcg gtacttggtt taatacccgt tcatggaatg acaaggaaag acagccgatt 3540
attgattggt ttcttcatgc tcgtaaattg ggatgggata ttatttttct tgttcaggat 3600attgattggt ttcttcatgc tcgtaaattg ggatgggata ttaatttttct tgttcaggat 3600
ttatctattg ttgataaaca ggcgcgttct gcattagctg aacacgttgt ttattgtcgc 3660ttatctattg ttgataaaca ggcgcgttct gcattagctg aacacgttgt ttaattgtcgc 3660
cgtctggaca gaattacttt accctttgtc ggcactttat attctcttgt tactggctca 3720cgtctggaca gaattacttt accctttgtc ggcactttat attctcttgt tactggctca 3720
aaaatgcctc tgcctaaatt acatgttggt gttgttaaat atggtgattc tcaattaagc 3780aaaatgcctc tgcctaaatt acatgttggt gttgttaaat atggtgattc tcaattaagc 3780
cctactgttg agcgttggct ttatactggt aagaatttat ataacgcata tgacactaaa 3840cctactgttg agcgttggct ttatactggt aagaatttat ataacgcata tgacactaaa 3840
caggcttttt ccagtaatta tgattcaggt gtttattcat atttaacccc ttatttatca 3900caggcttttt ccagtaatta tgattcaggt gtttaattcat atttaaccccc ttattatca 3900
cacggtcggt atttcaaacc attaaattta ggtcagaaga tgaaattaac taaaatatat 3960cacggtcggt atttcaaacc attaaattta ggtcagaaga tgaaattaac taaaatatat 3960
ttgaaaaagt tttctcgcgt tctttgtctt gcgataggat ttgcatcagc atttacatat 4020ttgaaaaagt tttctcgcgt tctttgtctt gcgataggat ttgcatcagc atttacatat 4020
agttatataa cccaacctaa gccggaggtt aaaaaggtag tctctcagac ctatgatttt 4080agttatataa cccaacctaa gccggaggtt aaaaaggtag tctctcagac ctatgatttt 4080
gataaattca ctattgactc ttctcagcgt cttaatctaa gctatcgcta tgttttcaag 4140gataaattca ctattgactc ttctcagcgt cttaatctaa gctatcgcta tgttttcaag 4140
gattctaagg gaaaattaat taatagcgac gatttacaga agcaaggtta ttccatcaca 4200gattctaagg gaaaattaat taatagcgac gatttacaga agcaaggtta ttccatcaca 4200
tatattgatt tatgtactgt ttcaattaaa aaaggtaatt caaatgaaat tgttaaatgt 4260tatattgatt tatgtactgt ttcaattaaa aaaggtaatt caaatgaaat tgttaaatgt 4260
aattaatttt gttttcttga tgtttgtttc atcatcttct tttgctcaag taattgaaat 4320aattaatttt gttttcttga tgtttgtttc atcatcttct tttgctcaag taattgaaat 4320
gaataattcg cctctgcgcg atttcgtgac ttggtattca aagcaaacag gtgaatctgt 4380gaataattcg cctctgcgcg atttcgtgac ttggtattca aagcaaacag gtgaatctgt 4380
tattgtctca cctgatgtta aaggtacagt gactgtatat tcctctgacg ttaagcctga 4440tattgtctca cctgatgtta aaggtacagt gactgtatat tcctctgacg ttaagcctga 4440
aaatttacgc aatttcttta tctctgtttt acgtgctaat aattttgata tggttggctc 4500aaatttacgc aatttcttta tctctgtttt acgtgctaat aattttgata tggttggctc 4500
aattccttcc ataattcaga aatataaccc aaatagtcag gattatattg atgaattgcc 4560aattccttcc ataattcaga aatataaccc aaatagtcag gattatattg atgaattgcc 4560
atcatctgat attcaggaat atgatgataa ttccgctcct tctggtggtt tctttgttcc 4620atcatctgat attcaggaat atgatgataa ttccgctcct tctggtggtt tctttgttcc 4620
gcaaaatgat aatgttactc aaacatttaa aattaataac gttcgcgcaa aggatttaat 4680gcaaaatgat aatgttactc aaacatttaa aattaataac gttcgcgcaa aggatttaat 4680
aagggttgta gaattgtttg ttaaatctaa tacatctaaa tcctcaaatg tattatctgt 4740aagggttgta gaattgtttg ttaaatctaa tacatctaaa tcctcaaatg tattatctgt 4740
tgatggttct aacttattag tagttagcgc ccctaaagat attttagata accttccgca 4800tgatggttct aacttattag tagttagcgc ccctaaagat attttagata accttccgca 4800
atttctttct actgttgatt tgccaactga ccagatattg attgaaggat taattttcga 4860atttctttct actgttgatt tgccaactga ccagatattg attgaaggat taattttcga 4860
ggttcagcaa ggtgatgctt tagatttttc ctttgctgct ggctctcagc gcggcactgt 4920ggttcagcaa ggtgatgctt tagatttttc ctttgctgct ggctctcagc gcggcactgt 4920
tgctggtggt gttaatactg accgtctaac ctctgtttta tcttctgcgg gtggttcgtt 4980tgctggtggt gttaatactg accgtctaac ctctgtttta tcttctgcgg gtggttcgtt 4980
cggtattttt aacggcgatg ttttagggct atcagttcgc gcattaaaga ctaatagcca 5040cggtattttt aacggcgatg ttttagggct atcagttcgc gcattaaaga ctaatagcca 5040
ttcaaaaata ttgtctgtgc ctcgtattct tacgctttca ggtcagaagg gttctatttc 5100ttcaaaaata ttgtctgtgc ctcgtattct tacgctttca ggtcagaagg gttctatttc 5100
tgttggccag aatgtccctt ttattactgg tcgtgtaact ggtgaatctg ccaatgtaaa 5160tgttggccag aatgtccctt ttaattactgg tcgtgtaact ggtgaatctg ccaatgtaaa 5160
taatccattt cagacggttg agcgtcaaaa tgttggtatt tctatgagtg tttttcccgt 5220taatccattt cagacggttg agcgtcaaaa tgttggtatt tctatgagtg tttttcccgt 5220
tgcaatggct ggcggtaata ttgttttaga tataaccagt aaggccgata gtttgagttc 5280tgcaatggct ggcggtaata ttgttttaga tataaccagt aaggccgata gtttgagttc 5280
ttctactcag gcaagtgatg ttattactaa tcaaagaagt attgcgacaa cggttaattt 5340ttctactcag gcaagtgatg ttattactaa tcaaagaagt attgcgacaa cggttaattt 5340
gcgtgatggt cagactcttt tgctcggtgg cctcactgat tacaaaaaca cttctcaaga 5400gcgtgatggt cagactcttt tgctcggtgg cctcactgat tacaaaaaca cttctcaaga 5400
ttctggtgtg ccgttcctgt ctaaaatccc tttaatcggc ctcctgttta gctcccgttc 5460ttctggtgtg ccgttcctgt ctaaaatccc tttaatcggc ctcctgttta gctcccgttc 5460
tgattctaac gaggaaagca cgttgtacgt gctcgtcaaa gcaaccatag tacgcgccct 5520tgattctaac gaggaaagca cgttgtacgt gctcgtcaaa gcaaccatag tacgcgccct 5520
gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg cagcgtgacc gctacacttg 5580gtagcggcgc attaagcgcg gcgggtgtgg tggttacgcg cagcgtgacc gctacacttg 5580
ccagcgccct agcgcccgct cctttcgctt tcttcccttc ctttctcgcc acgttctccg 5640ccagcgccct agcgcccgct cctttcgctt tcttcccttc ctttctcgcc acgttctccg 5640
gctttccccg tcaagctcta aatcggggga gctcgagctt actccccatc cccctgttga 5700gctttccccg tcaagctcta aatcggggga gctcgagctt actccccatc cccctgttga 5700
caattaatca tcggctcgta taatgtgtgg aattgtgagc ggataacaat ttcttaatgg 5760caattaatca tcggctcgta taatgtgtgg aattgtgagc ggataacaat ttcttaatgg 5760
aaacttcctc atgaaaaagt ctttagttct taaagcatct gttgctgttg cgactcttgt 5820aaacttcctc atgaaaaagt ctttagttct taaagcatct gttgctgttg cgactcttgt 5820
tcctatgcta agctttgcca acgtccctgc agaaggtgat gacccggcta aagctgcttt 5880tcctatgcta agctttgcca acgtccctgc agaaggtgat gacccggcta aagctgcttt 5880
tgactctctt caggcttctg ctactgaata catcggctac gcttgggcta tggtggttgt 5940tgactctctt caggcttctg ctactgaata catcggctac gcttgggcta tggtggttgt 5940
tatcgttggt gctactattg gcatcaaact tttcaaaaaa ttcacttcta aagcgtctta 6000tatcgttggt gctactattg gcatcaaact tttcaaaaaa ttcacttcta aagcgtctta 6000
atgaactcag atacccagcc cgcctaatga gcgggctttt ttttaagcta gcttatgatg 6060atgaactcag atacccagcc cgcctaatga gcgggctttt ttttaagcta gcttatgatg 6060
atgatgtgct taaaaactta ctcaatggct ggtttatgca tatcgcaata catgcgaaaa 6120atgatgtgct taaaaactta ctcaatggct ggtttatgca tatcgcaata catgcgaaaa 6120
acctaaaaga gcttgccgat aaaaaaggcc aatttattgc tatttaccgc ggctttttat 6180acctaaaaga gcttgccgat aaaaaaggcc aatttattgc tattaccgc ggctttttat 6180
tgagcttgaa agataaataa aatagatagg ttttatttga agctaaatct tctttatcgt 6240tgagcttgaa agataaataa aatagatagg ttttatttga agctaaatct tctttatcgt 6240
aaaaaatgcc ctcttgggtt atcaagaggg tcattatatt tcgcggaata acatcatttg 6300aaaaaatgcc ctcttgggtt atcaagaggg tcatttatatt tcgcggaata acatcatttg 6300
gtgacgaaat aactaagcac ttgtctcctg tttactcccc tgagcttgag gggttaacat 6360gtgacgaaat aactaagcac ttgtctcctg tttactcccc tgagcttgag gggttaacat 6360
gaaggtcatc gatagcagga taataataca gtaaaacgct aaaccaataa tccaaatcca 6420gaaggtcatc gatagcagga taataataca gtaaaacgct aaaccaataa tccaaatcca 6420
gccatcccaa attggtagtg aatgattata aataacagca aacagtaatg ggccaataac 6480gccatcccaa attggtagtg aatgattata aataacagca aacagtaatg ggccaataac 6480
accggttgca ttggtaaggc tcaccaataa tccctgtaaa gcaccttgct gatgactctt 6540accggttgca ttggtaaggc tcaccaataa tccctgtaaa gcaccttgct gatgactctt 6540
tgtttggata gacatcactc cctgtaatgc aggtaaagcg atcccaccac cagccaataa 6600tgtttggata gacatcactc cctgtaatgc aggtaaagcg atcccaccac cagccaataa 6600
aattaaaaca gggaaaacta accaaccttc agatataaac gctaaaaagg caaatgcact 6660aattaaaaca gggaaaacta accaaccttc agatataaac gctaaaaagg caaatgcact 6660
actatctgca ataaatccga gcagtactgc cgttttttcg ccccatttag tggctattct 6720actatctgca ataaatccga gcagtactgc cgttttttcg ccccatttag tggctattct 6720
tcctgccaca aaggcttgga atactgagtg taaaagacca agacccgcta atgaaaagcc 6780tcctgccaca aaggcttgga atactgagtg taaaagacca agacccgcta atgaaaagcc 6780
aaccatcatg ctattccatc caaaacgatt ttcggtaaat agcacccaca ccgttgcggg 6840aaccatcatg ctattccatc caaaacgatt ttcggtaaat agcacccaca ccgttgcggg 6840
aatttggcct atcaattgcg ctgaaaaata aataatcaac aaaatgggca tcgttttaaa 6900aatttggcct atcaattgcg ctgaaaaata aataatcaac aaaatgggca tcgttttaaa 6900
taaagtgatg tataccgaat tcgattgcgt ctcaacccct acttcggtat ctgtattatc 6960taaagtgatg tataccgaat tcgattgcgt ctcaacccct acttcggtat ctgtattatc 6960
acgtgtattt ttggtttcac ggaaccaaaa cataaccaca aggaaagtga caatatttag 7020acgtgtatttttggtttcac ggaaccaaaa cataaccaca aggaaagtga caatatttag 7020
caacgcagcg ataaaaaagg gactatgcgg tgaaatctct cctgcaaaac caccaataat 7080caacgcagcg ataaaaaagg gactatgcgg tgaaatctct cctgcaaaac caccaataat 7080
aggccccgct attaaaccaa gcccaaaact tgcccctaac caaccgaacc acttcacgcg 7140aggccccgct attaaaccaa gcccaaaact tgcccctaac caaccgaacc acttcacgcg 7140
ttgagaagct gaggtggtat cggcaatgac cgatgccgcg acagccccag tagctcctgt 7200ttgagaagct gaggtggtat cggcaatgac cgatgccgcg acagccccag tagctcctgt 7200
gatccctgaa agcaaacggc ctaaatacag catccaaagc gcacttgaaa aagccagcaa 7260gatccctgaa agcaaacggc ctaaatacag catccaaagc gcacttgaaa aagccagcaa 7260
taagtaatcc agcgatgcgc ctattaatga caacaacagc actgggcgcc gaccaaatcg 7320taagtaatcc agcgatgcgc ctattaatga caacaacagc actgggcgcc gaccaaatcg 7320
gtcagacatt tttccaagcc aaggagcaaa gataacctgc attaacgcat aaagtgcaag 7380gtcagacatt tttccaagcc aaggagcaaa gataacctgc attaacgcat aaagtgcaag 7380
caatacgcca aagtggttag cgatatcttc cgaagcaata aattcacgta ataacgttgg 7440caatacgcca aagtggttag cgatatcttc cgaagcaata aattcacgta ataacgttgg 7440
caagactggc atgataaggc caatccccat ggcatcgagt aacgtaatta ccaatgcgat 7500caagactggc atgataaggc caatccccat ggcatcgagt aacgtaatta ccaatgcgat 7500
ctttgtcgaa ctattcattt cacttttctc tatcactgat agggagtggt aaaataactc 7560ctttgtcgaa ctattcattt cacttttctc tatcactgat agggagtggt aaaataactc 7560
tatcaatgat agagtgtcaa caaaaattag gaattaatga tgtctagatt agataaaagt 7620tatcaatgat agagtgtcaa caaaaattag gaattaatga tgtctagatt agataaaagt 7620
aaagtgatta acagcgcatt agagctgctt aatgaggtcg gaatcgaagg tttaacaacc 7680aaagtgatta acagcgcatt agagctgctt aatgaggtcg gaatcgaagg tttaacaacc 7680
cgtaaactcg cccagaagct aggtgtagag cagcctacat tgtattggca tgtaaaaaat 7740cgtaaactcg cccagaagct aggtgtagag cagcctacat tgtattggca tgtaaaaaat 7740
aagcgggctt tgctcgacgc cttagccatt gagatgttag ataggcacca tactcacttt 7800aagcgggctt tgctcgacgc cttagccatt gagatgttag ataggcacca tactcacttt 7800
tgccctttag aaggggaaag ctggcaagat tttttacgta ataacgctaa aagttttaga 7860tgccctttag aaggggaaag ctggcaagat tttttacgta ataacgctaa aagttttaga 7860
tgtgctttac taagtcatcg cgatggagca aaagtacatt taggtacacg gcctacagaa 7920tgtgctttac taagtcatcg cgatggagca aaagtacatt taggtacacg gcctacagaa 7920
aaacagtatg aaactctcga aaatcaatta gcctttttat gccaacaagg tttttcacta 7980aaacagtatg aaactctcga aaatcaatta gcctttttat gccaacaagg tttttcacta 7980
gagaatgcat tatatgcact cagcgctgtg gggcatttta ctttaggttg cgtattggaa 8040gagaatgcat tatatgcact cagcgctgtg gggcatttta ctttaggttg cgtattggaa 8040
gatcaagagc atcaagtcgc taaagaagaa agggaaacac ctactactga tagtatgccg 8100gatcaagagc atcaagtcgc taaagaagaa agggaaacac ctactactga tagtatgccg 8100
ccattattac gacaagctat cgaattattt gatcaccaag gtgcagagcc agccttctta 8160ccattattac gacaagctat cgaattattt gatcaccaag gtgcagagcc agccttctta 8160
ttcggccttg aattgatcat atgcggatta gaaaaacaac ttaaatgtga aagtgggtct 8220ttcggccttg aattgatcat atgcggatta gaaaaacaac ttaaatgtga aagtgggtct 8220
taaaagcagc ataacctttt tccgtgatgg taacttcacg gtaaccaaga tgtcgagtta 8280taaaagcagc ataacctttt tccgtgatgg taacttcacg gtaaccaaga tgtcgagtta 8280
accacccttt agattcataa agcgaaaata atgcggctcc aacgtaccca cctaaatgga 8340accaccccttt agattcataa agcgaaaata atgcggctcc aacgtaccca cctaaatgga 8340
aacggcgttc actccaatct aaacacgcac aacagatttt acgtgaatgt ttggaaggaa 8400aacggcgttc actccaatct aaacacgcac aacagatttt acgtgaatgt ttggaaggaa 8400
cgtcaattcc catttcatga aaatattgaa taccacttaa tgtgatcatt gaaccatttt 8460cgtcaattcc catttcatga aaatattgaa taccacttaa tgtgatcatt gaaccatttt 8460
cagtgatcca ttgctgttga caaagggaat catagatccc tttagggttc cgatttagtg 8520cagtgatcca ttgctgttga caaagggaat catagatccc tttagggttc cgattagtg 8520
ctttacggca cctcgacctc caaaaacttg atttgggtga tggttcacgt agtgggccat 8580ctttacggca cctcgacctc caaaaacttg atttgggtga tggttcacgt agtgggccat 8580
cgccctgata gacggttttt cgccctttga cgttggagtc cacgttcttt aatagtggac 8640cgccctgata gacggttttt cgccctttga cgttggagtc cacgttcttt aatagtggac 8640
tcttgttcca aactggaaca acactcacaa ctaactcggc ctattctttt gatttataag 8700tcttgttcca aactggaaca acactcacaa ctaactcggc ctattctttt gatttataag 8700
gatttttgtc attttctgct tactggttaa aaaataagct gatttaacaa atatttaacg 8760gatttttgtc attttctgct tactggttaa aaaataagct gatttaacaa atatttaacg 8760
cgaaatttaa caaaacatta acgtttacaa tttaaatatt tgcttataca atcatcctgt 8820cgaaatttaa caaaacatta acgtttacaa tttaaatatt tgcttataca atcatcctgt 8820
ttttggggct tttctgatta tcaatcgggg tacatatgat tgacatgcta gttttacgat 8880ttttggggct tttctgatta tcaatcgggg tacatatgat tgacatgcta gttttacgat 8880
taccgttcat cgattctctt gtttgctcca gactttcagg taatgacctg atagcctttg 8940taccgttcat cgattctctt gtttgctcca gactttcagg taatgacctg atagcctttg 8940
tagacctctc aaaaatagct accctctccg gcatgaattt atcagctaga acggttgaat 9000tagacctctc aaaaatagct accctctccg gcatgaattt atcagctaga acggttgaat 9000
atcatattga cggtgatttg actgtctccg gcctttctca cccgtttgaa tctttgccta 9060atcatattga cggtgatttg actgtctccg gcctttctca cccgtttgaa tctttgccta 9060
ctcattactc cggcattgca tttaaaatat atgagggttc taaaaatttt tatccctgcg 9120ctcattactc cggcattgca tttaaaatat atgagggttc taaaaatttt tatccctgcg 9120
ttgaaattaa ggcttcacca gcaaaagtat tacagggtca taatgttttt ggtacaaccg 9180ttgaaattaa ggcttcacca gcaaaagtat tacagggtca taatgttttt ggtacaaccg 9180
atttagcttt atgctctgag gctttattgc ttaattttgc taactctctg ccttgcttgt 9240atttagcttt atgctctgag gctttattgc ttaattttgc taactctctg ccttgcttgt 9240
acgatttatt ggatgtt 9257acgattatt ggatgtt 9257
<210> 11<210> 11
<211> 43<211> 43
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 11<400> 11
ccacgctgcg caagctcaaa attataagga agatgccagg caa 43ccacgctgcg caagctcaaa attataagga agatgccagg caa 43
<210> 12<210> 12
<211> 51<211> 51
<212> DNA<212>DNA
<213> 人工设计<213> artificial design
<400> 12<400> 12
tgcgatagcc tccgatgagg ctaaacctgg tgccatactc cctcgcttcg t 51tgcgatagcc tccgatgagg ctaaacctgg tgccatactc cctcgcttcg t 51
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710161741.1A CN106906187A (en) | 2017-03-17 | 2017-03-17 | A kind of bi-functional bacteriophage and purposes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710161741.1A CN106906187A (en) | 2017-03-17 | 2017-03-17 | A kind of bi-functional bacteriophage and purposes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106906187A true CN106906187A (en) | 2017-06-30 |
Family
ID=59187539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710161741.1A Pending CN106906187A (en) | 2017-03-17 | 2017-03-17 | A kind of bi-functional bacteriophage and purposes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106906187A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110211628A (en) * | 2019-06-12 | 2019-09-06 | 湖南大学 | A kind of lysogenic phage prediction technique based on high-flux sequence data |
CN113214358A (en) * | 2020-04-17 | 2021-08-06 | 青岛大学 | Short peptide, detection kit and method for detecting vascular endothelial growth factor |
CN113528467A (en) * | 2021-06-24 | 2021-10-22 | 新乡学院 | Targeting double-display phage and preparation method and application thereof |
CN115043908A (en) * | 2022-06-10 | 2022-09-13 | 浙江大学 | Hydroxyapatite targeting peptide and application thereof |
CN119144569A (en) * | 2024-11-20 | 2024-12-17 | 浙江大学 | Double-display phage and construction method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105018507A (en) * | 2014-04-17 | 2015-11-04 | 东北师范大学 | Phage vector for dual-epitope display and construction method thereof |
-
2017
- 2017-03-17 CN CN201710161741.1A patent/CN106906187A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105018507A (en) * | 2014-04-17 | 2015-11-04 | 东北师范大学 | Phage vector for dual-epitope display and construction method thereof |
Non-Patent Citations (2)
Title |
---|
PING AN,ET AL.: "SUPPRESSION OF TUMOR GROWTH AND METASTASIS BY A VEGFR-1 ANTAGONIZING PEPTIDE IDENTIFIED FROM A PHAGE DISPLAY LIBRARY", 《INT. J. CANCER》 * |
侍立峰,等: "VEGF受体3高亲和噬菌体融合肽的筛选及亲和功能研究", 《西南国防医药》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110211628A (en) * | 2019-06-12 | 2019-09-06 | 湖南大学 | A kind of lysogenic phage prediction technique based on high-flux sequence data |
CN110211628B (en) * | 2019-06-12 | 2022-06-07 | 湖南大学 | Lysogenic phage prediction method based on high-throughput sequencing data |
CN113214358A (en) * | 2020-04-17 | 2021-08-06 | 青岛大学 | Short peptide, detection kit and method for detecting vascular endothelial growth factor |
CN113214358B (en) * | 2020-04-17 | 2022-03-15 | 青岛大学 | Short peptide, detection kit and method for detecting vascular endothelial growth factor |
CN113528467A (en) * | 2021-06-24 | 2021-10-22 | 新乡学院 | Targeting double-display phage and preparation method and application thereof |
CN113528467B (en) * | 2021-06-24 | 2023-12-01 | 新乡学院 | Targeting double-display phage and preparation method and application thereof |
CN115043908A (en) * | 2022-06-10 | 2022-09-13 | 浙江大学 | Hydroxyapatite targeting peptide and application thereof |
CN115043908B (en) * | 2022-06-10 | 2023-10-13 | 浙江大学 | A kind of hydroxyapatite targeting peptide and its use |
CN119144569A (en) * | 2024-11-20 | 2024-12-17 | 浙江大学 | Double-display phage and construction method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106906187A (en) | A kind of bi-functional bacteriophage and purposes | |
Noren et al. | Construction of high-complexity combinatorial phage display peptide libraries | |
KR101597840B1 (en) | p VII phage display | |
US5498538A (en) | Totally synthetic affinity reagents | |
CA2710140C (en) | Polypeptide libraries with a predetermined scaffold | |
AU684510B2 (en) | Method for selection of biologically active peptide sequences | |
CA2092803A1 (en) | Surface expression libraries of randomized peptides | |
KR20080039869A (en) | New phage display method | |
JP2011507521A (en) | Human non-antibody peptide or protein phage library | |
McConnell et al. | Construction and screening of M13 phage libraries displaying long random peptides | |
WO2025011106A1 (en) | Biosynthesis method for broad-spectrum antiviral polypeptide | |
CN106868032A (en) | It is a kind of can dystopy show the double display carriers of two kinds of bacteriophages of polypeptide | |
Wright et al. | Binding epitope of somatostatin defined by phage-displayed peptide libraries | |
JPH08505524A (en) | Soluble peptide having a secondary conformation constrained in solution, and process for producing the same | |
CN102060913A (en) | Heptapeptide combined with human serum albumin and application thereof | |
Kuzmicheva et al. | Peptide phage display in biotechnology and biomedicine | |
Dorgham et al. | Generating chemokine analogs with enhanced pharmacological properties using phage display | |
Kay | Biologically displayed random peptides as reagents in mapping protein-protein interactions | |
CN117447560A (en) | Bicyclic peptide ligands, pharmaceutical preparations, screening methods and uses targeting EGFR | |
CN116120438B (en) | Nanobody of targeting novel coronavirus RBD structural domain and derivative protein thereof | |
CN111518801A (en) | A kind of constitutive lactic acid bacteria promoter, recombinant vector and its recombinant bacteria and application | |
Vispo et al. | Displaying human interleukin-2 on the surface of bacteriophage | |
WO2021197212A1 (en) | Phage drug-protein display system and use thereof | |
WO2007114139A1 (en) | Phage display by novel filamentous bacteriophage | |
US20100249377A1 (en) | ENGINEERED HYBIRD PHAGE VECTORS FOR THE DESIGN AND THE GENERATION OF A HUMAN NON-ANTIBODY PEPTIDE OR PROTEIN PHAGE LIBRARY VIA FUSION TO pIX OF M13 PHAGE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20210209 |